Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.
The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.
Infections with viruses of the genus RESPIROVIRUS, family PARAMYXOVIRIDAE. Host cell infection occurs by adsorption, via HEMAGGLUTININ, to the cell surface.
A species of PNEUMOVIRUS causing an important respiratory infection in cattle. Symptoms include fever, conjunctivitis, and respiratory distress.
Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.
An acute inflammatory disease of the lower RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.
Inflammation of the BRONCHIOLES.
Glycoprotein from Sendai, para-influenza, Newcastle Disease, and other viruses that participates in binding the virus to cell-surface receptors. The HN protein possesses both hemagglutinin and neuraminidase activity.
Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
The top portion of the pharynx situated posterior to the nose and superior to the SOFT PALATE. The nasopharynx is the posterior extension of the nasal cavities and has a respiratory function.
A subfamily of the family MURIDAE comprised of 69 genera. New World mice and rats are included in this subfamily.
Inflammation of the lung parenchyma that is caused by a viral infection.
Immunoglobulins produced in response to VIRAL ANTIGENS.
Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.
Substances elaborated by viruses that have antigenic activity.
Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells.
Inbred BALB/c mice are a strain of laboratory mice that have been selectively bred to be genetically identical to each other, making them useful for scientific research and experiments due to their consistent genetic background and predictable responses to various stimuli or treatments.
A genus of the subfamily PNEUMOVIRINAE, containing two members: Turkey rhinotracheitis virus and a human Metapneumovirus. Virions lack HEMAGGLUTININ and NEURAMINIDASE.
Fluid obtained by THERAPEUTIC IRRIGATION or washout of the nasal cavity and NASAL MUCOSA. The resulting fluid is used in cytologic and immunologic assays of the nasal mucosa such as with the NASAL PROVOCATION TEST in the diagnosis of nasal hypersensitivity.
The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.
An infant during the first month after birth.
Proteins found in any species of virus.
Inflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
A copper-containing dye used as a gelling agent for lubricants, for staining of bacteria and for the dyeing of histiocytes and fibroblasts in vivo.
A histochemical technique for staining carbohydrates. It is based on PERIODIC ACID oxidation of a substance containing adjacent hydroxyl groups. The resulting aldehydes react with Schiff reagent to form a colored product.
Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.
A part of the upper respiratory tract. It contains the organ of SMELL. The term includes the external nose, the nasal cavity, and the PARANASAL SINUSES.
A subfamily of MURIDAE found nearly world-wide and consisting of about 20 genera. Voles, lemmings, and muskrats are members.
The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells.
Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus.
The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).
Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.
Infections with viruses of the family PARAMYXOVIRIDAE. This includes MORBILLIVIRUS INFECTIONS; RESPIROVIRUS INFECTIONS; PNEUMOVIRUS INFECTIONS; HENIPAVIRUS INFECTIONS; AVULAVIRUS INFECTIONS; and RUBULAVIRUS INFECTIONS.
A general term for diseases produced by viruses.
Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.
Established cell cultures that have the potential to propagate indefinitely.
Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy.
Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.
Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung.
Noises, normal and abnormal, heard on auscultation over any part of the RESPIRATORY TRACT.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
The confinement of a patient in a hospital.
Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells.
The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
The viscous secretion of mucous membranes. It contains mucin, white blood cells, water, inorganic salts, and exfoliated cells.
A species of RESPIROVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia.
Antibodies produced by a single clone of cells.
The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.
Process of growing viruses in live animals, plants, or cultured cells.
The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.
Viruses whose genetic material is RNA.
Ribonucleic acid that makes up the genetic material of viruses.
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
Elements of limited time intervals, contributing to particular results or situations.
The mucous membrane lining the RESPIRATORY TRACT, including the NASAL CAVITY; the LARYNX; the TRACHEA; and the BRONCHI tree. The respiratory mucosa consists of various types of epithelial cells ranging from ciliated columnar to simple squamous, mucous GOBLET CELLS, and glands containing both mucous and serous cells.
Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.
Disease having a short and relatively severe course.
Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
Animals or humans raised in the absence of a particular disease-causing virus or other microorganism. Less frequently plants are cultivated pathogen-free.
A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes.
Subset of helper-inducer T-lymphocytes which synthesize and secrete the interleukins IL-4, IL-5, IL-6, and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses.
A CELL LINE derived from the kidney of the African green (vervet) monkey, (CERCOPITHECUS AETHIOPS) used primarily in virus replication studies and plaque assays.
A cytokine synthesized by T-LYMPHOCYTES that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-LYMPHOCYTES. It appears to play a role in regulating inflammatory and immune responses.
Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).
A genus of the family PARAMYXOVIRIDAE (subfamily PARAMYXOVIRINAE) where all the virions have both HEMAGGLUTININ and NEURAMINIDASE activities and encode a non-structural C protein. SENDAI VIRUS is the type species.
Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif.
A species of the genus PNEUMOVIRUS causing pneumonia in mice.
The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI.
Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey (C. pygerythrus) is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.
The expelling of virus particles from the body. Important routes include the respiratory tract, genital tract, and intestinal tract. Virus shedding is an important means of vertical transmission (INFECTIOUS DISEASE TRANSMISSION, VERTICAL).
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
A family of RNA viruses causing INFLUENZA and other diseases. There are five recognized genera: INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; ISAVIRUS; and THOGOTOVIRUS.
Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.
A species of RESPIROVIRUS, subfamily PARAMYXOVIRINAE, most often seen in conjunction with a secondary infection of MANNHEIMIA HAEMOLYTICA resulting in pneumonic pasteurellosis (PASTEURELLOSIS, PNEUMONIC).
Infections with viruses of the genus PNEUMOVIRUS, family PARAMYXOVIRIDAE. This includes RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, an important cause of respiratory disease in humans.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.
Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.
The study of the structure, growth, function, genetics, and reproduction of viruses, and VIRUS DISEASES.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
A genus of the family PARAMYXOVIRIDAE (subfamily PNEUMOVIRINAE) where the human and bovine virions have neither hemagglutinin nor neuraminidase activity. RESPIRATORY SYNCYTIAL VIRUS, HUMAN is the type species.
A species of RESPIROVIRUS also called hemadsorption virus 2 (HA2), which causes laryngotracheitis in humans, especially children.
A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.
Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE.
A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918.
Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response.
Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.
The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children.
The functional hereditary units of VIRUSES.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
The assembly of VIRAL STRUCTURAL PROTEINS and nucleic acid (VIRAL DNA or VIRAL RNA) to form a VIRUS PARTICLE.
A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells.
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
A family of spherical viruses, of the order MONONEGAVIRALES, somewhat larger than the orthomyxoviruses, and containing single-stranded RNA. Subfamilies include PARAMYXOVIRINAE and PNEUMOVIRINAE.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Virus diseases caused by the ORTHOMYXOVIRIDAE.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
A form of fluorescent antibody technique utilizing a fluorochrome conjugated to an antibody, which is added directly to a tissue or cell suspension for the detection of a specific antigen. (Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)
Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.
A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
The type species of the genus INFLUENZAVIRUS A that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces.
Refers to animals in the period of time just after birth.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 2. The H3N2 subtype was responsible for the Hong Kong flu pandemic of 1968.
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS.
RNA virus infections refer to diseases caused by viruses that have RNA as their genetic material, which includes a wide range of pathogens affecting humans, animals, and plants, manifesting in various clinical symptoms and potentially leading to significant morbidity and mortality.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 1. The H5N1 subtype, frequently referred to as the bird flu virus, is endemic in wild birds and very contagious among both domestic (POULTRY) and wild birds. It does not usually infect humans, but some cases have been reported.
Viruses parasitic on plants higher than bacteria.
The type species of RESPIROVIRUS in the subfamily PARAMYXOVIRINAE. It is the murine version of HUMAN PARAINFLUENZA VIRUS 1, distinguished by host range.
The type species of ALPHAVIRUS normally transmitted to birds by CULEX mosquitoes in Egypt, South Africa, India, Malaya, the Philippines, and Australia. It may be associated with fever in humans. Serotypes (differing by less than 17% in nucleotide sequence) include Babanki, Kyzylagach, and Ockelbo viruses.
Viruses whose nucleic acid is DNA.
Species of the genus INFLUENZAVIRUS B that cause HUMAN INFLUENZA and other diseases primarily in humans. Antigenic variation is less extensive than in type A viruses (INFLUENZA A VIRUS) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with INFLUENZA A VIRUS and there have been no pandemics. Previously only found in humans, Influenza B virus has been isolated from seals which may constitute the animal reservoir from which humans are exposed.
Deoxyribonucleic acid that makes up the genetic material of viruses.

Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. (1/1345)

Interferon gamma (IFN-gamma) has pleiotropic biological effects, including intrinsic antiviral activity as well as stimulation and regulation of immune responses. An infectious recombinant human respiratory syncytial virus (rRSV/mIFN-gamma) was constructed that encodes murine (m) IFN-gamma as a separate gene inserted into the G-F intergenic region. Cultured cells infected with rRSV/mIFN-gamma secreted 22 microg mIFN-gamma per 10(6) cells. The replication of rRSV/mIFN-gamma, but not that of a control chimeric rRSV containing the chloramphenicol acetyl transferase (CAT) gene as an additional gene, was 63- and 20-fold lower than that of wild-type (wt) RSV in the upper and lower respiratory tract, respectively, of mice. Thus, the attenuation of rRSV/mIFN-gamma in vivo could be attributed to the activity of mIFN-gamma and not to the presence of the additional gene per se. The mice were completely resistant to subsequent challenge with wt RSV. Despite its growth restriction, infection of mice with rRSV/mIFN-gamma induced a level of RSV-specific antibodies that, on day 56, was comparable to or greater than that induced by infection with wt RSV. Mice infected with rRSV/mIFN-gamma developed a high level of IFN-gamma mRNA and an increased amount of interleukin 12 p40 mRNA in their lungs, whereas other cytokine mRNAs tested were unchanged compared with those induced by wt RSV. Because attenuation of RSV typically is accompanied by a reduction in immunogenicity, expression of IFN-gamma by an rRSV represents a method of attenuation in which immunogenicity can be maintained rather than be reduced.  (+info)

Two neutralizing human anti-RSV antibodies: cloning, expression, and characterization. (2/1345)

BACKGROUND: Respiratory syncytial virus (RSV) infection is a major problem in the newborn and aging populations. Fully human monoclonal antibodies with the ability to neutralize RSV could have a major impact on the immunotherapy of the disease. The generation of human antibodies has been difficult because there exists no general way to activate B cells against an antigen of choice in vitro. MATERIALS AND METHODS: Human spleen cells from individuals exposed to RSV were used to repopulate SCID mice. Hu-SCID mice were boosted with RSV fusion (F)-protein and subsequently developed B cell tumors. The tumors were removed and cultured and subcloned in vitro, using a feeder layer of CD154-expressing T cells. Two of these tumors produced the antibodies designated RF-1 and RF-2. VL genes were isolated by standard PCR techniques, however, it was necessary to use high-temperature reverse transcriptase to clone the VH genes. RESULTS: RF-1 and RF-2 VH genes were both found to be closely related members of the VH2 family. Vk genes originated from the VK III family. RF-1 and RF-2 recombinant antibodies expressed in CHO cells (cRF-1 and cRF-2) were found to have affinities for RSV F-protein of 0.1 nM and 0.07 nM, respectively, and both were able to neutralize several A and B subtypes of RSV. CONCLUSION: The technique of immortalizing human B lymphocytes, by passage in SCID mice and expression as recombinant antibodies in CHO cells, provides a method by which high-affinity human antibodies can be developed for immunotherapy of viral diseases.  (+info)

IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. (3/1345)

Viral respiratory infections can cause bronchial hyperresponsiveness and exacerbate asthma. In mice, respiratory syncytial virus (RSV) infection, which induces an immune response dominated by IFN-gamma, results in airway hyperresponsiveness (AHR) and eosinophil influx into the airways, both of which are prevented by pretreatment with anti-IL-5 Ab. To delineate the role of IL-5, IL-4, and IFN-gamma in the development of RSV-induced AHR and lung eosinophilia, we tested the ability of mice deficient in each of these cytokines to develop these symptoms of RSV infection. Mice deficient in either IL-5, IL-4, or IFN-gamma were administered infectious RSV intranasally, and 6 days later, airway responsiveness to inhaled methacholine was assessed by barometric body plethysmography, and numbers of lung eosinophils and production of IFN-gamma, IL-4, and IL-5 by mononuclear cells from peribronchial lymph nodes were monitored. RSV infection resulted in airway eosinophilia and AHR in both IL-4- and IFN-gamma-deficient mice, but not in IL-5-deficient mice. Reconstitution of IL-5-deficient mice with IL-5 restored these responses and enhanced the responses in IL-4-deficient mice. Anti-VLA-4 (very late Ag-4) treatment prevented lung eosinophilia and AHR following RSV infection and IL-5 reconstitution. We conclude that in response to RSV, IL-5 is essential for the influx of eosinophils into the lung and that eosinophils in turn are critical for the development of AHR. IFN-gamma and IL-4 are not essential for these responses to RSV infection.  (+info)

Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. (4/1345)

A number of antibodies generated during human respiratory syncytial virus (RSV) infection have been cloned by the phage library approach. Antibodies reactive with an immunodominant epitope on the F glycoprotein of this virus have a high affinity for affinity-purified F antigen. These antibodies, however, have a much lower affinity for mature F glycoprotein on the surface of infected cells and are nonneutralizing. In contrast, a potent neutralizing antibody has a high affinity for mature F protein but a much lower affinity for purified F protein or F protein in viral lysates. The data indicate that at least two F protein immunogens are produced during natural RSV infection: immature F, found in viral lysates, and mature F, found on infected cells or virions. Binding studies with polyclonal human immunoglobulin G suggest that the antibody responses to the two immunogens are of similar magnitudes. Competitive binding studies suggest that overlap between the responses is relatively limited. A mature envelope with an antigenic configuration different from that of the immature envelope has an evolutionary advantage in that the infecting virus is less subject to neutralization by the humoral response to the immature envelope that inevitably arises following lysis of infected cells. Subunit vaccines may be at a disadvantage because they most often resemble immature envelope molecules and ignore this aspect of viral evasion.  (+info)

Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. (5/1345)

The NS2 and SH genes of respiratory syncytial virus (RSV) have been separately deleted from a recombinant wild-type RSV strain, A2 (M. N. Teng and P. L. Collins, J. Virol. 73:466-473, 1998; A. Bukreyev et al., J. Virol. 71:8973-8982, 1997; and this study). The resulting viruses, designated rA2DeltaNS2 and rA2DeltaSH, were administered to chimpanzees to evaluate their levels of attenuation and immunogenicity. Recombinant virus rA2DeltaNS2 replicated to moderate levels in the upper respiratory tract, was highly attenuated in the lower respiratory tract, and induced significant resistance to challenge with wild-type RSV. The replication of rA2DeltaSH virus was only moderately reduced in the lower, but not the upper, respiratory tract. However, chimpanzees infected with either virus developed significantly less rhinorrhea than those infected with wild-type RSV. These findings demonstrate that a recombinant RSV mutant lacking either the NS2 or SH gene is attenuated and indicate that these deletions may be useful as attenuating mutations in new, live recombinant RSV vaccine candidates for both pediatric and elderly populations. The DeltaSH mutation was incorporated into a recombinant form of the cpts248/404 vaccine candidate, was evaluated for safety in seronegative chimpanzees, and can now be evaluated as a vaccine for humans.  (+info)

Molecular epidemiology of respiratory syncytial virus in The Gambia. (6/1345)

Respiratory syncytial virus (RSV) infection in The Gambia occurs seasonally in association with the rainy season. This study examined the genetic variability of RSV isolates from four consecutive epidemics from 1993-6. Each epidemic was made up of a number of variants which were replaced in subsequent epidemics. Analysis of attachment (G) protein gene sequences showed that isolates were closely related to those observed in the rest of the world. However, many isolates from 1993 and 1994 were unlike other isolates observed in the developed world during this period and were more similar to isolates from 1984 in Europe. In addition, the most commonly observed genotype in the UK in the 1990s was not detected in The Gambia during this period.  (+info)

Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice. (7/1345)

RD3-0028, a benzodithiin compound, has antiviral activity against respiratory syncytial virus (RSV) in cell culture. We used a mouse model of RSV infection to determine the in vivo effect of RD3-0028. Cyclophosphamide (CYP)-treated, immunosuppressed mice were inoculated intranasally. The lungs of the mice were removed on day 4. The virus titers of the lungs of RD3-0028-treated mice were compared to the virus titers of the lungs of virus-inoculated, untreated control mice. In an effort to increase the therapeutic effectiveness of this compound, RD3-0028 was administered by aerosol to RSV-infected mice by using a head-exposure system. Aerosols generated from reservoirs containing RD3-0028 (7 mg/ml) administered for 2 h twice daily for 3 days significantly reduced the pulmonary titer of RSV-infected mice. It is clear that the minimal effective dose of RD3-0028 for RSV-infected mice is significantly less than that of ribavirin, the only compound currently available for use against RSV disease. Furthermore, the RD3-0028 aerosol administration appeared to protect the lungs of infected, CYP-treated mice against tissue damage, as evidenced by the preservation of the lung architecture and a reduction in pulmonary inflammatory infiltrates. RD3-0028 aerosol was not toxic for mice at the therapeutic dose. The present study demonstrates the effectiveness of aerosol administration of RD3-0028 for RSV-infected mice.  (+info)

A simple and reproducible method for collecting nasal secretions in frail elderly adults, for measurement of virus-specific IgA. (8/1345)

The standard method for collection of respiratory secretions, by use of a nasal wash (NW) to measure virus-specific IgA, is problematic in frail elderly adults. Therefore, a simplified collection approach using a nasal swab (NS) is described. NW and NS samples were collected from healthy young and frail elderly adults, and IgA titers to respiratory syncytial virus (RSV) fusion and attachment glycoproteins were determined by enzyme immunoassay. Correlation between IgA titers in NW and NS was excellent for each of the antigens (correlation coefficients,.71-.93). In addition, NS results were reproducible when frail elderly subjects were sampled several weeks apart and were nearly equivalent to results from NW samples. The ability to sample nasal secretions by use of an NS when an NW is not technically feasible will facilitate the study of mucosal immunity to RSV as well as the study of mucosal response to candidate RSV vaccines in frail elderly populations.  (+info)

Respiratory Syncytial Virus (RSV) infections refer to the clinical illnesses caused by the Respiratory Syncytial Virus. RSV is a highly contagious virus that spreads through respiratory droplets, contact with infected surfaces, or direct contact with infected people. It primarily infects the respiratory tract, causing inflammation and damage to the cells lining the airways.

RSV infections can lead to a range of respiratory illnesses, from mild, cold-like symptoms to more severe conditions such as bronchiolitis (inflammation of the small airways in the lungs) and pneumonia (infection of the lung tissue). The severity of the infection tends to depend on factors like age, overall health status, and presence of underlying medical conditions.

In infants and young children, RSV is a leading cause of bronchiolitis and pneumonia, often resulting in hospitalization. In older adults, people with weakened immune systems, and those with chronic heart or lung conditions, RSV infections can also be severe and potentially life-threatening.

Symptoms of RSV infection may include runny nose, cough, sneezing, fever, wheezing, and difficulty breathing. Treatment typically focuses on managing symptoms and providing supportive care, although hospitalization and more aggressive interventions may be necessary in severe cases or for high-risk individuals. Preventive measures such as hand hygiene, wearing masks, and avoiding close contact with infected individuals can help reduce the spread of RSV.

Respiratory Syncytial Viruses (RSV) are a common type of virus that cause respiratory infections, particularly in young children and older adults. They are responsible for inflammation and narrowing of the small airways in the lungs, leading to breathing difficulties and other symptoms associated with bronchiolitis and pneumonia.

The term "syncytial" refers to the ability of these viruses to cause infected cells to merge and form large multinucleated cells called syncytia, which is a characteristic feature of RSV infections. The virus spreads through respiratory droplets when an infected person coughs or sneezes, and it can also survive on surfaces for several hours, making transmission easy.

RSV infections are most common during the winter months and can cause mild to severe symptoms depending on factors such as age, overall health, and underlying medical conditions. While RSV is typically associated with respiratory illnesses in children, it can also cause significant disease in older adults and immunocompromised individuals. Currently, there is no vaccine available for RSV, but antiviral medications and supportive care are used to manage severe infections.

Respiratory Syncytial Virus (RSV) is a highly contagious virus that causes infections in the respiratory system. In humans, it primarily affects the nose, throat, lungs, and bronchioles (the airways leading to the lungs). It is a major cause of lower respiratory tract infections and bronchiolitis (inflammation of the small airways in the lung) in young children, but can also infect older children and adults.

Human Respiratory Syncytial Virus (hRSV) belongs to the family Pneumoviridae and is an enveloped, single-stranded, negative-sense RNA virus. The viral envelope contains two glycoproteins: the G protein, which facilitates attachment to host cells, and the F protein, which mediates fusion of the viral and host cell membranes.

Infection with hRSV typically occurs through direct contact with respiratory droplets from an infected person or contaminated surfaces. The incubation period ranges from 2 to 8 days, after which symptoms such as runny nose, cough, sneezing, fever, and wheezing may appear. In severe cases, particularly in infants, young children, older adults, and individuals with weakened immune systems, hRSV can cause pneumonia or bronchiolitis, leading to hospitalization and, in rare cases, death.

Currently, there is no approved vaccine for hRSV; however, passive immunization with palivizumab, a monoclonal antibody, is available for high-risk infants to prevent severe lower respiratory tract disease caused by hRSV. Supportive care and prevention of complications are the mainstays of treatment for hRSV infections.

Respiroviruses are a genus of viruses in the family *Paramyxoviridae* that includes several important human pathogens, such as parainfluenza virus (PIV) types 1, 2, and 3, and human respiratory syncytial virus (HRSV). These viruses are primarily transmitted through respiratory droplets and direct contact with infected individuals.

Respirovirus infections mainly affect the respiratory tract and can cause a range of symptoms, from mild upper respiratory tract illness to severe lower respiratory tract infections. The severity of the disease depends on various factors, including the age and overall health status of the infected individual.

Parainfluenza viruses are a common cause of acute respiratory infections in children, particularly in those under five years old. They can lead to croup, bronchitis, pneumonia, and other respiratory tract complications. In adults, PIV infections are usually less severe but can still cause upper respiratory symptoms, such as the common cold.

Human respiratory syncytial virus is another important respirovirus that primarily affects young children, causing bronchiolitis and pneumonia. Reinfection with HRSV can occur throughout life, although subsequent infections are typically less severe than the initial infection. In older adults and individuals with compromised immune systems, HRSV infections can lead to serious complications, including pneumonia and exacerbation of chronic lung diseases.

Prevention strategies for respirovirus infections include good personal hygiene practices, such as frequent handwashing and covering the mouth and nose when coughing or sneezing. Vaccines are not available for most respiroviruses; however, research is ongoing to develop effective vaccines against these viruses, particularly HRSV.

Respiratory Syncytial Virus (RSV), bovine refers to a species-specific strain of the Respiratory Syncytial Virus that primarily infects cattle. It is a member of the Pneumoviridae family and Orthopneumovirus genus. This virus is closely related to human RSV, and it can cause respiratory infections in young calves, leading to symptoms such as nasal discharge, coughing, difficulty breathing, and pneumonia.

Bovine RSV shares many similarities with its human counterpart, including the ability to form syncytia (multinucleated giant cells) in infected tissues. However, bovine RSV is not known to infect humans or cause disease in humans. It is primarily studied as a model organism for understanding the biology and pathogenesis of RSV infections in general.

Respiratory Syncytial Virus (RSV) vaccines are immunizations designed to protect against the RSV infection, which is a major cause of respiratory tract illnesses in infants and young children worldwide. The virus can also cause serious illness in older adults and people with weakened immune systems.

There are currently no approved RSV vaccines available on the market, although several candidates are in various stages of development and clinical trials. Most of the vaccine candidates are aimed at preventing severe lower respiratory tract disease caused by RSV infection in infants and young children.

RSV vaccines typically work by stimulating the immune system to produce antibodies against the virus, which can help prevent infection or reduce the severity of symptoms if infection occurs. Some vaccine candidates use live-attenuated viruses, while others use inactivated viruses or viral proteins to induce an immune response.

While RSV vaccines have shown promise in clinical trials, developing a safe and effective vaccine has proven challenging due to the risk of vaccine-associated enhanced respiratory disease (VAERD), a rare but serious complication that can occur when certain types of RSV vaccines are given to people who have previously been infected with the virus. Therefore, ongoing research is focused on developing vaccines that can safely and effectively protect against RSV infection while minimizing the risk of VAERD.

Viral bronchiolitis is a common respiratory infection in infants and young children, typically caused by a viral pathogen such as the respiratory syncytial virus (RSV). The infection leads to inflammation and congestion of the small airways (bronchioles) in the lungs, resulting in symptoms like wheezing, cough, difficulty breathing, and rapid breathing.

The infection usually spreads through respiratory droplets when an infected person coughs or sneezes. The virus can also survive on surfaces for several hours, making it easy to contract the infection by touching contaminated objects and then touching the face.

Most cases of viral bronchiolitis are mild and resolve within 1-2 weeks with supportive care, including increased fluid intake, humidified air, and fever reduction. However, in severe cases or in high-risk infants (such as those born prematurely or with underlying heart or lung conditions), hospitalization may be necessary to manage complications like dehydration, respiratory distress, or oxygen deprivation.

Preventive measures include good hand hygiene, avoiding close contact with sick individuals, and ensuring that infants and young children receive appropriate vaccinations and immunizations as recommended by their healthcare provider.

Bronchiolitis is a common respiratory infection in infants and young children, typically caused by a viral infection. It is characterized by inflammation and congestion of the bronchioles (the smallest airways in the lungs), which can lead to difficulty breathing and wheezing.

The most common virus that causes bronchiolitis is respiratory syncytial virus (RSV), but other viruses such as rhinovirus, influenza, and parainfluenza can also cause the condition. Symptoms of bronchiolitis may include cough, wheezing, rapid breathing, difficulty feeding, and fatigue.

In severe cases, bronchiolitis can lead to respiratory distress and require hospitalization. Treatment typically involves supportive care, such as providing fluids and oxygen therapy, and in some cases, medications to help open the airways may be used. Prevention measures include good hand hygiene and avoiding close contact with individuals who are sick.

I'm sorry for any confusion, but "HN protein" is not a widely recognized or established medical term. HN is an abbreviation commonly used in virology to refer to the hemagglutinin-neuraminidase protein found on the surface of certain viruses, such as the paramyxoviridae family which includes viruses like parainfluenza and Hendra virus.

The HN protein plays a crucial role in the virus's ability to infect host cells. It helps the virus attach to and enter the host cell, and also assists in the release of new virus particles from infected cells. However, without more specific context, it's difficult to provide a more precise definition of "HN protein." If you have more details about the context in which this term was used, I'd be happy to try to provide a more specific answer.

Respiratory tract infections (RTIs) are infections that affect the respiratory system, which includes the nose, throat (pharynx), voice box (larynx), windpipe (trachea), bronchi, and lungs. These infections can be caused by viruses, bacteria, or, less commonly, fungi.

RTIs are classified into two categories based on their location: upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs). URTIs include infections of the nose, sinuses, throat, and larynx, such as the common cold, flu, laryngitis, and sinusitis. LRTIs involve the lower airways, including the bronchi and lungs, and can be more severe. Examples of LRTIs are pneumonia, bronchitis, and bronchiolitis.

Symptoms of RTIs depend on the location and cause of the infection but may include cough, congestion, runny nose, sore throat, difficulty breathing, wheezing, fever, fatigue, and chest pain. Treatment for RTIs varies depending on the severity and underlying cause of the infection. For viral infections, treatment typically involves supportive care to manage symptoms, while antibiotics may be prescribed for bacterial infections.

The nasopharynx is the uppermost part of the pharynx (throat), which is located behind the nose. It is a muscular cavity that serves as a passageway for air and food. The nasopharynx extends from the base of the skull to the lower border of the soft palate, where it continues as the oropharynx. Its primary function is to allow air to flow into the respiratory system through the nostrils while also facilitating the drainage of mucus from the nose into the throat. The nasopharynx contains several important structures, including the adenoids and the opening of the Eustachian tubes, which connect the middle ear to the back of the nasopharynx.

Sigmodontinae is a subfamily of rodents, more specifically within the family Cricetidae. This group is commonly known as the New World rats and mice, and it includes over 300 species that are primarily found in North, Central, and South America. The members of Sigmodontinae vary greatly in size and habits, with some being arboreal while others live on the ground or burrow. Some species have specialized diets, such as eating insects or seeds, while others are more generalist feeders. This subfamily is also notable for its high degree of speciation and diversity, making it an interesting subject for evolutionary biologists and ecologists.

Viral pneumonia is a type of pneumonia caused by viral infection. It primarily affects the upper and lower respiratory tract, leading to inflammation of the alveoli (air sacs) in the lungs. This results in symptoms such as cough, difficulty breathing, fever, fatigue, and chest pain. Common viruses that can cause pneumonia include influenza virus, respiratory syncytial virus (RSV), and adenovirus. Viral pneumonia is often milder than bacterial pneumonia but can still be serious, especially in young children, older adults, and people with weakened immune systems. Treatment typically involves supportive care, such as rest, hydration, and fever reduction, while the body fights off the virus. In some cases, antiviral medications may be used to help manage symptoms and prevent complications.

Antibodies, viral are proteins produced by the immune system in response to an infection with a virus. These antibodies are capable of recognizing and binding to specific antigens on the surface of the virus, which helps to neutralize or destroy the virus and prevent its replication. Once produced, these antibodies can provide immunity against future infections with the same virus.

Viral antibodies are typically composed of four polypeptide chains - two heavy chains and two light chains - that are held together by disulfide bonds. The binding site for the antigen is located at the tip of the Y-shaped structure, formed by the variable regions of the heavy and light chains.

There are five classes of antibodies in humans: IgA, IgD, IgE, IgG, and IgM. Each class has a different function and is distributed differently throughout the body. For example, IgG is the most common type of antibody found in the bloodstream and provides long-term immunity against viruses, while IgA is found primarily in mucous membranes and helps to protect against respiratory and gastrointestinal infections.

In addition to their role in the immune response, viral antibodies can also be used as diagnostic tools to detect the presence of a specific virus in a patient's blood or other bodily fluids.

A lung is a pair of spongy, elastic organs in the chest that work together to enable breathing. They are responsible for taking in oxygen and expelling carbon dioxide through the process of respiration. The left lung has two lobes, while the right lung has three lobes. The lungs are protected by the ribcage and are covered by a double-layered membrane called the pleura. The trachea divides into two bronchi, which further divide into smaller bronchioles, leading to millions of tiny air sacs called alveoli, where the exchange of gases occurs.

An antigen is any substance that can stimulate an immune response, particularly the production of antibodies. Viral antigens are antigens that are found on or produced by viruses. They can be proteins, glycoproteins, or carbohydrates present on the surface or inside the viral particle.

Viral antigens play a crucial role in the immune system's recognition and response to viral infections. When a virus infects a host cell, it may display its antigens on the surface of the infected cell. This allows the immune system to recognize and target the infected cells for destruction, thereby limiting the spread of the virus.

Viral antigens are also important targets for vaccines. Vaccines typically work by introducing a harmless form of a viral antigen to the body, which then stimulates the production of antibodies and memory T-cells that can recognize and respond quickly and effectively to future infections with the actual virus.

It's worth noting that different types of viruses have different antigens, and these antigens can vary between strains of the same virus. This is why there are often different vaccines available for different viral diseases, and why flu vaccines need to be updated every year to account for changes in the circulating influenza virus strains.

Viral fusion proteins are specialized surface proteins found on the envelope of enveloped viruses. These proteins play a crucial role in the viral infection process by mediating the fusion of the viral membrane with the target cell membrane, allowing the viral genetic material to enter the host cell and initiate replication.

The fusion protein is often synthesized as an inactive precursor, which undergoes a series of conformational changes upon interaction with specific receptors on the host cell surface. This results in the exposure of hydrophobic fusion peptides or domains that insert into the target cell membrane, bringing the two membranes into close proximity and facilitating their merger.

A well-known example of a viral fusion protein is the gp120/gp41 complex found on the Human Immunodeficiency Virus (HIV). The gp120 subunit binds to CD4 receptors and chemokine coreceptors on the host cell surface, triggering conformational changes in the gp41 subunit that expose the fusion peptide and enable membrane fusion. Understanding the structure and function of viral fusion proteins is important for developing antiviral strategies and vaccines.

BALB/c is an inbred strain of laboratory mouse that is widely used in biomedical research. The strain was developed at the Institute of Cancer Research in London by Henry Baldwin and his colleagues in the 1920s, and it has since become one of the most commonly used inbred strains in the world.

BALB/c mice are characterized by their black coat color, which is determined by a recessive allele at the tyrosinase locus. They are also known for their docile and friendly temperament, making them easy to handle and work with in the laboratory.

One of the key features of BALB/c mice that makes them useful for research is their susceptibility to certain types of tumors and immune responses. For example, they are highly susceptible to developing mammary tumors, which can be induced by chemical carcinogens or viral infection. They also have a strong Th2-biased immune response, which makes them useful models for studying allergic diseases and asthma.

BALB/c mice are also commonly used in studies of genetics, neuroscience, behavior, and infectious diseases. Because they are an inbred strain, they have a uniform genetic background, which makes it easier to control for genetic factors in experiments. Additionally, because they have been bred in the laboratory for many generations, they are highly standardized and reproducible, making them ideal subjects for scientific research.

Metapneumovirus is a type of virus that can cause respiratory infections in humans and animals. The human metapneumovirus (HMPV) is a leading cause of acute respiratory infection (ARI), particularly in young children, the elderly, and people with weakened immune systems. It is associated with a wide range of clinical manifestations, ranging from mild upper respiratory symptoms to severe bronchiolitis and pneumonia.

HMPV is an enveloped, single-stranded RNA virus that belongs to the Pneumoviridae family, subfamily Pneumovirinae, and genus Metapneumovirus. It was first identified in 2001, although it is believed to have been circulating in humans for at least 50 years before its discovery. HMPV is transmitted through respiratory droplets and direct contact with infected individuals or contaminated surfaces.

The incubation period of HMPV ranges from 3 to 6 days, after which symptoms such as cough, fever, nasal congestion, sore throat, and difficulty breathing may appear. In severe cases, HMPV can lead to bronchitis, bronchiolitis, or pneumonia, requiring hospitalization, especially in high-risk populations. Currently, there is no specific antiviral treatment for HMPV infections, and management typically involves supportive care, such as oxygen therapy, hydration, and respiratory support if necessary. Prevention measures include good hand hygiene, wearing masks, and avoiding close contact with infected individuals.

Nasal lavage fluid refers to the fluid that is obtained through a process called nasal lavage or nasal washing. This procedure involves instilling a saline solution into the nose and then allowing it to drain out, taking with it any mucus, debris, or other particles present in the nasal passages. The resulting fluid can be collected and analyzed for various purposes, such as diagnosing sinus infections, allergies, or other conditions affecting the nasal cavity and surrounding areas.

It is important to note that the term "nasal lavage fluid" may also be used interchangeably with "nasal wash fluid," "nasal irrigation fluid," or "sinus rinse fluid." These terms all refer to the same basic concept of using a saline solution to clean out the nasal passages and collect the resulting fluid for analysis.

Virus replication is the process by which a virus produces copies or reproduces itself inside a host cell. This involves several steps:

1. Attachment: The virus attaches to a specific receptor on the surface of the host cell.
2. Penetration: The viral genetic material enters the host cell, either by invagination of the cell membrane or endocytosis.
3. Uncoating: The viral genetic material is released from its protective coat (capsid) inside the host cell.
4. Replication: The viral genetic material uses the host cell's machinery to produce new viral components, such as proteins and nucleic acids.
5. Assembly: The newly synthesized viral components are assembled into new virus particles.
6. Release: The newly formed viruses are released from the host cell, often through lysis (breaking) of the cell membrane or by budding off the cell membrane.

The specific mechanisms and details of virus replication can vary depending on the type of virus. Some viruses, such as DNA viruses, use the host cell's DNA polymerase to replicate their genetic material, while others, such as RNA viruses, use their own RNA-dependent RNA polymerase or reverse transcriptase enzymes. Understanding the process of virus replication is important for developing antiviral therapies and vaccines.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Viral proteins are the proteins that are encoded by the viral genome and are essential for the viral life cycle. These proteins can be structural or non-structural and play various roles in the virus's replication, infection, and assembly process. Structural proteins make up the physical structure of the virus, including the capsid (the protein shell that surrounds the viral genome) and any envelope proteins (that may be present on enveloped viruses). Non-structural proteins are involved in the replication of the viral genome and modulation of the host cell environment to favor viral replication. Overall, a thorough understanding of viral proteins is crucial for developing antiviral therapies and vaccines.

Bronchopneumonia is a type of pneumonia that involves inflammation and infection of the bronchioles (small airways in the lungs) and alveoli (tiny air sacs in the lungs). It can be caused by various bacteria, viruses, or fungi and often occurs as a complication of a respiratory tract infection.

The symptoms of bronchopneumonia may include cough, chest pain, fever, chills, shortness of breath, and fatigue. In severe cases, it can lead to complications such as respiratory failure or sepsis. Treatment typically involves antibiotics for bacterial infections, antiviral medications for viral infections, and supportive care such as oxygen therapy and hydration.

Antiviral agents are a class of medications that are designed to treat infections caused by viruses. Unlike antibiotics, which target bacteria, antiviral agents interfere with the replication and infection mechanisms of viruses, either by inhibiting their ability to replicate or by modulating the host's immune response to the virus.

Antiviral agents are used to treat a variety of viral infections, including influenza, herpes simplex virus (HSV) infections, human immunodeficiency virus (HIV) infection, hepatitis B and C, and respiratory syncytial virus (RSV) infections.

These medications can be administered orally, intravenously, or topically, depending on the type of viral infection being treated. Some antiviral agents are also used for prophylaxis, or prevention, of certain viral infections.

It is important to note that antiviral agents are not effective against all types of viruses and may have significant side effects. Therefore, it is essential to consult with a healthcare professional before starting any antiviral therapy.

Alcian Blue is a type of dye that is commonly used in histology, which is the study of the microscopic structure of tissues. It is particularly useful for staining acidic mucopolysaccharides and proteoglycans, which are important components of the extracellular matrix in many tissues.

Alcian Blue binds to these negatively charged molecules through ionic interactions, forming a complex that can be visualized under a microscope. The dye is often used in combination with other stains to provide contrast and highlight specific structures within tissues.

The intensity of the Alcian Blue stain can also provide information about the degree of sulfation or carboxylation of the mucopolysaccharides, which can be useful in diagnosing certain diseases or abnormalities. For example, changes in the staining pattern of proteoglycans have been associated with various types of arthritis and other joint disorders.

Overall, Alcian Blue is an important tool in the field of histology and has contributed significantly to our understanding of tissue structure and function.

The Periodic Acid-Schiff (PAS) reaction is a histological staining method used to detect the presence of certain carbohydrates, such as glycogen and glycoproteins, in tissues or cells. This technique involves treating the tissue with periodic acid, which oxidizes the vicinal hydroxyl groups in the carbohydrates, creating aldehydes. The aldehydes then react with Schiff's reagent, forming a magenta-colored complex that is visible under a microscope.

The PAS reaction is commonly used to identify and analyze various tissue components, such as basement membranes, fungal cell walls, and mucins in the respiratory and gastrointestinal tracts. It can also be used to diagnose certain medical conditions, like kidney diseases, where abnormal accumulations of carbohydrates occur in the renal tubules or glomeruli.

In summary, the Periodic Acid-Schiff reaction is a staining method that detects specific carbohydrates in tissues or cells, which can aid in diagnostic and research applications.

Viral envelope proteins are structural proteins found in the envelope that surrounds many types of viruses. These proteins play a crucial role in the virus's life cycle, including attachment to host cells, fusion with the cell membrane, and entry into the host cell. They are typically made up of glycoproteins and are often responsible for eliciting an immune response in the host organism. The exact structure and function of viral envelope proteins vary between different types of viruses.

A nose, in a medical context, refers to the external part of the human body that is located on the face and serves as the primary organ for the sense of smell. It is composed of bone and cartilage, with a thin layer of skin covering it. The nose also contains nasal passages that are lined with mucous membranes and tiny hairs known as cilia. These structures help to filter, warm, and moisturize the air we breathe in before it reaches our lungs. Additionally, the nose plays an essential role in the process of verbal communication by shaping the sounds we make when we speak.

Arvicolinae is a subfamily of rodents that includes voles, lemmings, and muskrats. These small mammals are characterized by their short legs, rounded bodies, and short tails. They are primarily found in the northern hemisphere, with the majority of species living in North America and Eurasia.

Arvicolines are known for their high reproductive rate and ability to survive in a variety of habitats, including grasslands, forests, tundra, and wetlands. They have a unique set of teeth called hypsodont teeth, which continue to grow throughout their lives. This adaptation allows them to wear down their teeth as they gnaw on tough plant material.

Many arvicoline species are important prey animals for larger predators, such as hawks, owls, and foxes. Some species, like the muskrat, are also hunted by humans for their fur or meat. In recent years, some arvicoline populations have experienced dramatic fluctuations in size due to changes in their habitats and food supplies, leading to concerns about their conservation status.

Nasal mucosa refers to the mucous membrane that lines the nasal cavity. It is a delicate, moist, and specialized tissue that contains various types of cells including epithelial cells, goblet cells, and glands. The primary function of the nasal mucosa is to warm, humidify, and filter incoming air before it reaches the lungs.

The nasal mucosa produces mucus, which traps dust, allergens, and microorganisms, preventing them from entering the respiratory system. The cilia, tiny hair-like structures on the surface of the epithelial cells, help move the mucus towards the back of the throat, where it can be swallowed or expelled.

The nasal mucosa also contains a rich supply of blood vessels and immune cells that help protect against infections and inflammation. It plays an essential role in the body's defense system by producing antibodies, secreting antimicrobial substances, and initiating local immune responses.

Cattle diseases are a range of health conditions that affect cattle, which include but are not limited to:

1. Bovine Respiratory Disease (BRD): Also known as "shipping fever," BRD is a common respiratory illness in feedlot cattle that can be caused by several viruses and bacteria.
2. Bovine Viral Diarrhea (BVD): A viral disease that can cause a variety of symptoms, including diarrhea, fever, and reproductive issues.
3. Johne's Disease: A chronic wasting disease caused by the bacterium Mycobacterium avium subspecies paratuberculosis. It primarily affects the intestines and can cause severe diarrhea and weight loss.
4. Digital Dermatitis: Also known as "hairy heel warts," this is a highly contagious skin disease that affects the feet of cattle, causing lameness and decreased productivity.
5. Infectious Bovine Keratoconjunctivitis (IBK): Also known as "pinkeye," IBK is a common and contagious eye infection in cattle that can cause blindness if left untreated.
6. Salmonella: A group of bacteria that can cause severe gastrointestinal illness in cattle, including diarrhea, dehydration, and septicemia.
7. Leptospirosis: A bacterial disease that can cause a wide range of symptoms in cattle, including abortion, stillbirths, and kidney damage.
8. Blackleg: A highly fatal bacterial disease that causes rapid death in young cattle. It is caused by Clostridium chauvoei and vaccination is recommended for prevention.
9. Anthrax: A serious infectious disease caused by the bacterium Bacillus anthracis. Cattle can become infected by ingesting spores found in contaminated soil, feed or water.
10. Foot-and-Mouth Disease (FMD): A highly contagious viral disease that affects cloven-hooved animals, including cattle. It is characterized by fever and blisters on the feet, mouth, and teats. FMD is not a threat to human health but can have serious economic consequences for the livestock industry.

It's important to note that many of these diseases can be prevented or controlled through good management practices, such as vaccination, biosecurity measures, and proper nutrition. Regular veterinary care and monitoring are also crucial for early detection and treatment of any potential health issues in your herd.

Neutralization tests are a type of laboratory assay used in microbiology and immunology to measure the ability of a substance, such as an antibody or antitoxin, to neutralize the activity of a toxin or infectious agent. In these tests, the substance to be tested is mixed with a known quantity of the toxin or infectious agent, and the mixture is then incubated under controlled conditions. After incubation, the mixture is tested for residual toxicity or infectivity using a variety of methods, such as cell culture assays, animal models, or biochemical assays.

The neutralization titer is then calculated based on the highest dilution of the test substance that completely neutralizes the toxin or infectious agent. Neutralization tests are commonly used in the diagnosis and evaluation of immune responses to vaccines, as well as in the detection and quantification of toxins and other harmful substances.

Examples of neutralization tests include the serum neutralization test for measles antibodies, the plaque reduction neutralization test (PRNT) for dengue virus antibodies, and the cytotoxicity neutralization assay for botulinum neurotoxins.

I'm sorry for any confusion, but "seasons" is not a term that has a medical definition. Seasons refer to the four divisions of the year (spring, summer, autumn or fall, and winter) based on the position of the earth in its orbit around the sun. If you have any questions related to health or medicine, I'd be happy to try to help answer those!

Ribavirin is an antiviral medication used in the treatment of certain viral infections, including hepatitis C and respiratory syncytial virus (RSV) infection. It works by interfering with viral replication, preventing the virus from multiplying within infected cells. Ribavirin is often used in combination with other antiviral drugs for more effective treatment.

It's important to note that ribavirin can have serious side effects and should only be used under the supervision of a healthcare professional. Additionally, it is not effective against all types of viral infections and its use should be based on a confirmed diagnosis and appropriate medical evaluation.

Paramyxoviridae is a family of viruses that includes several important pathogens causing respiratory infections in humans and animals. According to the medical perspective, Paramyxoviridae infections refer to the diseases caused by these viruses.

Some notable human paramyxovirus infections include:

1. Respiratory Syncytial Virus (RSV) Infection: RSV is a common cause of respiratory tract infections, particularly in young children and older adults. It can lead to bronchiolitis and pneumonia, especially in infants and patients with compromised immune systems.
2. Measles (Rubeola): Measles is a highly contagious viral disease characterized by fever, cough, coryza (runny nose), conjunctivitis, and a maculopapular rash. It can lead to severe complications such as pneumonia, encephalitis, and even death, particularly in malnourished children and individuals with weakened immune systems.
3. Parainfluenza Virus Infection: Parainfluenza viruses are responsible for upper and lower respiratory tract infections, including croup, bronchitis, and pneumonia. They mainly affect young children but can also infect adults, causing mild to severe illnesses.
4. Mumps: Mumps is a contagious viral infection that primarily affects the salivary glands, causing painful swelling. It can lead to complications such as meningitis, encephalitis, deafness, and orchitis (inflammation of the testicles) in rare cases.
5. Human Metapneumovirus (HMPV) Infection: HMPV is a respiratory virus that can cause upper and lower respiratory tract infections, similar to RSV and parainfluenza viruses. It mainly affects young children and older adults, leading to bronchitis, pneumonia, and exacerbations of chronic lung diseases.

Prevention strategies for Paramyxoviridae infections include vaccination programs, practicing good personal hygiene, and implementing infection control measures in healthcare settings.

Viral diseases are illnesses caused by the infection and replication of viruses in host organisms. These infectious agents are obligate parasites, meaning they rely on the cells of other living organisms to survive and reproduce. Viruses can infect various types of hosts, including animals, plants, and microorganisms, causing a wide range of diseases with varying symptoms and severity.

Once a virus enters a host cell, it takes over the cell's machinery to produce new viral particles, often leading to cell damage or death. The immune system recognizes the viral components as foreign and mounts an immune response to eliminate the infection. This response can result in inflammation, fever, and other symptoms associated with viral diseases.

Examples of well-known viral diseases include:

1. Influenza (flu) - caused by influenza A, B, or C viruses
2. Common cold - usually caused by rhinoviruses or coronaviruses
3. HIV/AIDS - caused by human immunodeficiency virus (HIV)
4. Measles - caused by measles morbillivirus
5. Hepatitis B and C - caused by hepatitis B virus (HBV) and hepatitis C virus (HCV), respectively
6. Herpes simplex - caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2)
7. Chickenpox and shingles - both caused by varicella-zoster virus (VZV)
8. Rabies - caused by rabies lyssavirus
9. Ebola - caused by ebolaviruses
10. COVID-19 - caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Prevention and treatment strategies for viral diseases may include vaccination, antiviral medications, and supportive care to manage symptoms while the immune system fights off the infection.

Intravenous Immunoglobulins (IVIG) are a preparation of antibodies, specifically immunoglobulins, that are derived from the plasma of healthy donors. They are administered intravenously to provide passive immunity and help boost the immune system's response in individuals with weakened or compromised immune systems. IVIG can be used for various medical conditions such as primary immunodeficiency disorders, secondary immunodeficiencies, autoimmune diseases, and some infectious diseases. The administration of IVIG can help prevent infections, reduce the severity and frequency of infections, and manage the symptoms of certain autoimmune disorders. It is important to note that while IVIG provides temporary immunity, it does not replace a person's own immune system.

A cell line is a culture of cells that are grown in a laboratory for use in research. These cells are usually taken from a single cell or group of cells, and they are able to divide and grow continuously in the lab. Cell lines can come from many different sources, including animals, plants, and humans. They are often used in scientific research to study cellular processes, disease mechanisms, and to test new drugs or treatments. Some common types of human cell lines include HeLa cells (which come from a cancer patient named Henrietta Lacks), HEK293 cells (which come from embryonic kidney cells), and HUVEC cells (which come from umbilical vein endothelial cells). It is important to note that cell lines are not the same as primary cells, which are cells that are taken directly from a living organism and have not been grown in the lab.

The Fluorescent Antibody Technique (FAT) is a type of immunofluorescence assay used in laboratory medicine and pathology for the detection and localization of specific antigens or antibodies in tissues, cells, or microorganisms. In this technique, a fluorescein-labeled antibody is used to selectively bind to the target antigen or antibody, forming an immune complex. When excited by light of a specific wavelength, the fluorescein label emits light at a longer wavelength, typically visualized as green fluorescence under a fluorescence microscope.

The FAT is widely used in diagnostic microbiology for the identification and characterization of various bacteria, viruses, fungi, and parasites. It has also been applied in the diagnosis of autoimmune diseases and certain cancers by detecting specific antibodies or antigens in patient samples. The main advantage of FAT is its high sensitivity and specificity, allowing for accurate detection and differentiation of various pathogens and disease markers. However, it requires specialized equipment and trained personnel to perform and interpret the results.

Aerosols are defined in the medical field as suspensions of fine solid or liquid particles in a gas. In the context of public health and medicine, aerosols often refer to particles that can remain suspended in air for long periods of time and can be inhaled. They can contain various substances, such as viruses, bacteria, fungi, or chemicals, and can play a role in the transmission of respiratory infections or other health effects.

For example, when an infected person coughs or sneezes, they may produce respiratory droplets that can contain viruses like influenza or SARS-CoV-2 (the virus that causes COVID-19). Some of these droplets can evaporate quickly and leave behind smaller particles called aerosols, which can remain suspended in the air for hours and potentially be inhaled by others. This is one way that respiratory viruses can spread between people in close proximity to each other.

Aerosols can also be generated through medical procedures such as bronchoscopy, suctioning, or nebulizer treatments, which can produce aerosols containing bacteria, viruses, or other particles that may pose an infection risk to healthcare workers or other patients. Therefore, appropriate personal protective equipment (PPE) and airborne precautions are often necessary to reduce the risk of transmission in these settings.

An Enzyme-Linked Immunosorbent Assay (ELISA) is a type of analytical biochemistry assay used to detect and quantify the presence of a substance, typically a protein or peptide, in a liquid sample. It takes its name from the enzyme-linked antibodies used in the assay.

In an ELISA, the sample is added to a well containing a surface that has been treated to capture the target substance. If the target substance is present in the sample, it will bind to the surface. Next, an enzyme-linked antibody specific to the target substance is added. This antibody will bind to the captured target substance if it is present. After washing away any unbound material, a substrate for the enzyme is added. If the enzyme is present due to its linkage to the antibody, it will catalyze a reaction that produces a detectable signal, such as a color change or fluorescence. The intensity of this signal is proportional to the amount of target substance present in the sample, allowing for quantification.

ELISAs are widely used in research and clinical settings to detect and measure various substances, including hormones, viruses, and bacteria. They offer high sensitivity, specificity, and reproducibility, making them a reliable choice for many applications.

Cytokines are a broad and diverse category of small signaling proteins that are secreted by various cells, including immune cells, in response to different stimuli. They play crucial roles in regulating the immune response, inflammation, hematopoiesis, and cellular communication.

Cytokines mediate their effects by binding to specific receptors on the surface of target cells, which triggers intracellular signaling pathways that ultimately result in changes in gene expression, cell behavior, and function. Some key functions of cytokines include:

1. Regulating the activation, differentiation, and proliferation of immune cells such as T cells, B cells, natural killer (NK) cells, and macrophages.
2. Coordinating the inflammatory response by recruiting immune cells to sites of infection or tissue damage and modulating their effector functions.
3. Regulating hematopoiesis, the process of blood cell formation in the bone marrow, by controlling the proliferation, differentiation, and survival of hematopoietic stem and progenitor cells.
4. Modulating the development and function of the nervous system, including neuroinflammation, neuroprotection, and neuroregeneration.

Cytokines can be classified into several categories based on their structure, function, or cellular origin. Some common types of cytokines include interleukins (ILs), interferons (IFNs), tumor necrosis factors (TNFs), chemokines, colony-stimulating factors (CSFs), and transforming growth factors (TGFs). Dysregulation of cytokine production and signaling has been implicated in various pathological conditions, such as autoimmune diseases, chronic inflammation, cancer, and neurodegenerative disorders.

Bronchoalveolar lavage (BAL) fluid is a type of clinical specimen obtained through a procedure called bronchoalveolar lavage. This procedure involves inserting a bronchoscope into the lungs and instilling a small amount of saline solution into a specific area of the lung, then gently aspirating the fluid back out. The fluid that is recovered is called bronchoalveolar lavage fluid.

BAL fluid contains cells and other substances that are present in the lower respiratory tract, including the alveoli (the tiny air sacs where gas exchange occurs). By analyzing BAL fluid, doctors can diagnose various lung conditions, such as pneumonia, interstitial lung disease, and lung cancer. They can also monitor the effectiveness of treatments for these conditions by comparing the composition of BAL fluid before and after treatment.

BAL fluid is typically analyzed for its cellular content, including the number and type of white blood cells present, as well as for the presence of bacteria, viruses, or other microorganisms. The fluid may also be tested for various proteins, enzymes, and other biomarkers that can provide additional information about lung health and disease.

Respiratory sounds are the noises produced by the airflow through the respiratory tract during breathing. These sounds can provide valuable information about the health and function of the lungs and airways. They are typically categorized into two main types: normal breath sounds and adventitious (or abnormal) breath sounds.

Normal breath sounds include:

1. Vesicular breath sounds: These are soft, low-pitched sounds heard over most of the lung fields during quiet breathing. They are produced by the movement of air through the alveoli and smaller bronchioles.
2. Bronchovesicular breath sounds: These are medium-pitched, hollow sounds heard over the mainstem bronchi and near the upper sternal border during both inspiration and expiration. They are a combination of vesicular and bronchial breath sounds.

Abnormal or adventitious breath sounds include:

1. Crackles (or rales): These are discontinuous, non-musical sounds that resemble the crackling of paper or bubbling in a fluid-filled container. They can be heard during inspiration and are caused by the sudden opening of collapsed airways or the movement of fluid within the airways.
2. Wheezes: These are continuous, musical sounds resembling a whistle. They are produced by the narrowing or obstruction of the airways, causing turbulent airflow.
3. Rhonchi: These are low-pitched, rumbling, continuous sounds that can be heard during both inspiration and expiration. They are caused by the vibration of secretions or fluids in the larger airways.
4. Stridor: This is a high-pitched, inspiratory sound that resembles a harsh crowing or barking noise. It is usually indicative of upper airway narrowing or obstruction.

The character, location, and duration of respiratory sounds can help healthcare professionals diagnose various respiratory conditions, such as pneumonia, chronic obstructive pulmonary disease (COPD), asthma, and bronchitis.

Immunoglobulin G (IgG) is a type of antibody, which is a protective protein produced by the immune system in response to foreign substances like bacteria or viruses. IgG is the most abundant type of antibody in human blood, making up about 75-80% of all antibodies. It is found in all body fluids and plays a crucial role in fighting infections caused by bacteria, viruses, and toxins.

IgG has several important functions:

1. Neutralization: IgG can bind to the surface of bacteria or viruses, preventing them from attaching to and infecting human cells.
2. Opsonization: IgG coats the surface of pathogens, making them more recognizable and easier for immune cells like neutrophils and macrophages to phagocytose (engulf and destroy) them.
3. Complement activation: IgG can activate the complement system, a group of proteins that work together to help eliminate pathogens from the body. Activation of the complement system leads to the formation of the membrane attack complex, which creates holes in the cell membranes of bacteria, leading to their lysis (destruction).
4. Antibody-dependent cellular cytotoxicity (ADCC): IgG can bind to immune cells like natural killer (NK) cells and trigger them to release substances that cause target cells (such as virus-infected or cancerous cells) to undergo apoptosis (programmed cell death).
5. Immune complex formation: IgG can form immune complexes with antigens, which can then be removed from the body through various mechanisms, such as phagocytosis by immune cells or excretion in urine.

IgG is a critical component of adaptive immunity and provides long-lasting protection against reinfection with many pathogens. It has four subclasses (IgG1, IgG2, IgG3, and IgG4) that differ in their structure, function, and distribution in the body.

Hospitalization is the process of admitting a patient to a hospital for the purpose of receiving medical treatment, surgery, or other health care services. It involves staying in the hospital as an inpatient, typically under the care of doctors, nurses, and other healthcare professionals. The length of stay can vary depending on the individual's medical condition and the type of treatment required. Hospitalization may be necessary for a variety of reasons, such as to receive intensive care, to undergo diagnostic tests or procedures, to recover from surgery, or to manage chronic illnesses or injuries.

Epithelial cells are types of cells that cover the outer surfaces of the body, line the inner surfaces of organs and glands, and form the lining of blood vessels and body cavities. They provide a protective barrier against the external environment, regulate the movement of materials between the internal and external environments, and are involved in the sense of touch, temperature, and pain. Epithelial cells can be squamous (flat and thin), cuboidal (square-shaped and of equal height), or columnar (tall and narrow) in shape and are classified based on their location and function.

The Respiratory System is a complex network of organs and tissues that work together to facilitate the process of breathing, which involves the intake of oxygen and the elimination of carbon dioxide. This system primarily includes the nose, throat (pharynx), voice box (larynx), windpipe (trachea), bronchi, bronchioles, lungs, and diaphragm.

The nostrils or mouth take in air that travels through the pharynx, larynx, and trachea into the lungs. Within the lungs, the trachea divides into two bronchi, one for each lung, which further divide into smaller tubes called bronchioles. At the end of these bronchioles are tiny air sacs known as alveoli where the exchange of gases occurs. Oxygen from the inhaled air diffuses through the walls of the alveoli into the bloodstream, while carbon dioxide, a waste product, moves from the blood to the alveoli and is exhaled out of the body.

The diaphragm, a large muscle that separates the chest from the abdomen, plays a crucial role in breathing by contracting and relaxing to change the volume of the chest cavity, thereby allowing air to flow in and out of the lungs. Overall, the Respiratory System is essential for maintaining life by providing the body's cells with the oxygen needed for metabolism and removing waste products like carbon dioxide.

Influenza, also known as the flu, is a highly contagious viral infection that attacks the respiratory system of humans. It is caused by influenza viruses A, B, or C and is characterized by the sudden onset of fever, chills, headache, muscle pain, sore throat, cough, runny nose, and fatigue. Influenza can lead to complications such as pneumonia, bronchitis, and ear infections, and can be particularly dangerous for young children, older adults, pregnant women, and people with weakened immune systems or chronic medical conditions. The virus is spread through respiratory droplets produced when an infected person coughs, sneezes, or talks, and can also survive on surfaces for a period of time. Influenza viruses are constantly changing, which makes it necessary to get vaccinated annually to protect against the most recent and prevalent strains.

Mucus is a viscous, slippery secretion produced by the mucous membranes that line various body cavities such as the respiratory and gastrointestinal tracts. It serves to lubricate and protect these surfaces from damage, infection, and foreign particles. Mucus contains water, proteins, salts, and other substances, including antibodies, enzymes, and glycoproteins called mucins that give it its characteristic gel-like consistency.

In the respiratory system, mucus traps inhaled particles such as dust, allergens, and pathogens, preventing them from reaching the lungs. The cilia, tiny hair-like structures lining the airways, move the mucus upward toward the throat, where it can be swallowed or expelled through coughing or sneezing. In the gastrointestinal tract, mucus helps protect the lining of the stomach and intestines from digestive enzymes and other harmful substances.

Excessive production of mucus can occur in various medical conditions such as allergies, respiratory infections, chronic lung diseases, and gastrointestinal disorders, leading to symptoms such as coughing, wheezing, nasal congestion, and diarrhea.

Parainfluenza Virus 3, Human (HPIV-3) is an enveloped, single-stranded RNA virus that belongs to the family Paramyxoviridae and genus Respirovirus. It is one of the four serotypes of human parainfluenza viruses (HPIVs), which are important causes of acute respiratory tract infections in infants, young children, and immunocompromised individuals.

HPIV-3 primarily infects the upper and lower respiratory tract, causing a wide range of clinical manifestations, from mild to severe respiratory illnesses. The incubation period for HPIV-3 infection is typically 3-7 days. In infants and young children, HPIV-3 can cause croup (laryngotracheobronchitis), bronchiolitis, and pneumonia, while in adults, it usually results in mild upper respiratory tract infections, such as the common cold.

The virus is transmitted through direct contact with infected respiratory secretions or contaminated surfaces, and infection can occur throughout the year but tends to peak during fall and winter months. Currently, there are no approved vaccines for HPIV-3; treatment is primarily supportive and focuses on managing symptoms and complications.

Monoclonal antibodies are a type of antibody that are identical because they are produced by a single clone of cells. They are laboratory-produced molecules that act like human antibodies in the immune system. They can be designed to attach to specific proteins found on the surface of cancer cells, making them useful for targeting and treating cancer. Monoclonal antibodies can also be used as a therapy for other diseases, such as autoimmune disorders and inflammatory conditions.

Monoclonal antibodies are produced by fusing a single type of immune cell, called a B cell, with a tumor cell to create a hybrid cell, or hybridoma. This hybrid cell is then able to replicate indefinitely, producing a large number of identical copies of the original antibody. These antibodies can be further modified and engineered to enhance their ability to bind to specific targets, increase their stability, and improve their effectiveness as therapeutic agents.

Monoclonal antibodies have several mechanisms of action in cancer therapy. They can directly kill cancer cells by binding to them and triggering an immune response. They can also block the signals that promote cancer growth and survival. Additionally, monoclonal antibodies can be used to deliver drugs or radiation directly to cancer cells, increasing the effectiveness of these treatments while minimizing their side effects on healthy tissues.

Monoclonal antibodies have become an important tool in modern medicine, with several approved for use in cancer therapy and other diseases. They are continuing to be studied and developed as a promising approach to treating a wide range of medical conditions.

Interferon-gamma (IFN-γ) is a soluble cytokine that is primarily produced by the activation of natural killer (NK) cells and T lymphocytes, especially CD4+ Th1 cells and CD8+ cytotoxic T cells. It plays a crucial role in the regulation of the immune response against viral and intracellular bacterial infections, as well as tumor cells. IFN-γ has several functions, including activating macrophages to enhance their microbicidal activity, increasing the presentation of major histocompatibility complex (MHC) class I and II molecules on antigen-presenting cells, stimulating the proliferation and differentiation of T cells and NK cells, and inducing the production of other cytokines and chemokines. Additionally, IFN-γ has direct antiproliferative effects on certain types of tumor cells and can enhance the cytotoxic activity of immune cells against infected or malignant cells.

Virus cultivation, also known as virus isolation or viral culture, is a laboratory method used to propagate and detect viruses by introducing them to host cells and allowing them to replicate. This process helps in identifying the specific virus causing an infection and studying its characteristics, such as morphology, growth pattern, and sensitivity to antiviral agents.

The steps involved in virus cultivation typically include:

1. Collection of a clinical sample (e.g., throat swab, blood, sputum) from the patient.
2. Preparation of the sample by centrifugation or filtration to remove cellular debris and other contaminants.
3. Inoculation of the prepared sample into susceptible host cells, which can be primary cell cultures, continuous cell lines, or embryonated eggs, depending on the type of virus.
4. Incubation of the inoculated cells under appropriate conditions to allow viral replication.
5. Observation for cytopathic effects (CPE), which are changes in the host cells caused by viral replication, such as cell rounding, shrinkage, or lysis.
6. Confirmation of viral presence through additional tests, like immunofluorescence assays, polymerase chain reaction (PCR), or electron microscopy.

Virus cultivation is a valuable tool in diagnostic virology, vaccine development, and research on viral pathogenesis and host-virus interactions. However, it requires specialized equipment, trained personnel, and biosafety measures due to the potential infectivity of the viruses being cultured.

Viral load refers to the amount or quantity of virus (like HIV, Hepatitis C, SARS-CoV-2) present in an individual's blood or bodily fluids. It is often expressed as the number of virus copies per milliliter of blood or fluid. Monitoring viral load is important in managing and treating certain viral infections, as a higher viral load may indicate increased infectivity, disease progression, or response to treatment.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Vaccinia virus is a large, complex DNA virus that belongs to the Poxviridae family. It is the virus used in the production of the smallpox vaccine. The vaccinia virus is not identical to the variola virus, which causes smallpox, but it is closely related and provides cross-protection against smallpox infection.

The vaccinia virus has a unique replication cycle that occurs entirely in the cytoplasm of infected cells, rather than in the nucleus like many other DNA viruses. This allows the virus to evade host cell defenses and efficiently produce new virions. The virus causes the formation of pocks or lesions on the skin, which contain large numbers of virus particles that can be transmitted to others through close contact.

Vaccinia virus has also been used as a vector for the delivery of genes encoding therapeutic proteins, vaccines against other infectious diseases, and cancer therapies. However, the use of vaccinia virus as a vector is limited by its potential to cause adverse reactions in some individuals, particularly those with weakened immune systems or certain skin conditions.

RNA viruses are a type of virus that contain ribonucleic acid (RNA) as their genetic material, as opposed to deoxyribonucleic acid (DNA). RNA viruses replicate by using an enzyme called RNA-dependent RNA polymerase to transcribe and replicate their RNA genome.

There are several different groups of RNA viruses, including:

1. Negative-sense single-stranded RNA viruses: These viruses have a genome that is complementary to the mRNA and must undergo transcription to produce mRNA before translation can occur. Examples include influenza virus, measles virus, and rabies virus.
2. Positive-sense single-stranded RNA viruses: These viruses have a genome that can serve as mRNA and can be directly translated into protein after entry into the host cell. Examples include poliovirus, rhinoviruses, and coronaviruses.
3. Double-stranded RNA viruses: These viruses have a genome consisting of double-stranded RNA and use a complex replication strategy involving both transcription and reverse transcription. Examples include rotaviruses and reoviruses.

RNA viruses are known to cause a wide range of human diseases, ranging from the common cold to more severe illnesses such as hepatitis C, polio, and COVID-19. Due to their high mutation rates and ability to adapt quickly to new environments, RNA viruses can be difficult to control and treat with antiviral drugs or vaccines.

A viral RNA (ribonucleic acid) is the genetic material found in certain types of viruses, as opposed to viruses that contain DNA (deoxyribonucleic acid). These viruses are known as RNA viruses. The RNA can be single-stranded or double-stranded and can exist as several different forms, such as positive-sense, negative-sense, or ambisense RNA. Upon infecting a host cell, the viral RNA uses the host's cellular machinery to translate the genetic information into proteins, leading to the production of new virus particles and the continuation of the viral life cycle. Examples of human diseases caused by RNA viruses include influenza, COVID-19 (SARS-CoV-2), hepatitis C, and polio.

"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Respiratory mucosa refers to the mucous membrane that lines the respiratory tract, including the nose, throat, bronchi, and lungs. It is a specialized type of tissue that is composed of epithelial cells, goblet cells, and glands that produce mucus, which helps to trap inhaled particles such as dust, allergens, and pathogens.

The respiratory mucosa also contains cilia, tiny hair-like structures that move rhythmically to help propel the mucus and trapped particles out of the airways and into the upper part of the throat, where they can be swallowed or coughed up. This defense mechanism is known as the mucociliary clearance system.

In addition to its role in protecting the respiratory tract from harmful substances, the respiratory mucosa also plays a crucial role in immune function by containing various types of immune cells that help to detect and respond to pathogens and other threats.

Bronchial hyperresponsiveness (BHR) or bronchial hyperreactivity (BH) is a medical term that refers to the increased sensitivity and exaggerated response of the airways to various stimuli. In people with BHR, the airways narrow (constrict) more than usual in response to certain triggers such as allergens, cold air, exercise, or irritants like smoke or fumes. This narrowing can cause symptoms such as wheezing, coughing, chest tightness, and shortness of breath.

BHR is often associated with asthma and other respiratory conditions, including chronic obstructive pulmonary disease (COPD) and bronchiectasis. It is typically diagnosed through a series of tests that measure the degree of airway narrowing in response to various stimuli. These tests may include spirometry, methacholine challenge test, or histamine challenge test.

BHR can be managed with medications such as bronchodilators and anti-inflammatory drugs, which help to relax the muscles around the airways and reduce inflammation. It is also important to avoid triggers that can exacerbate symptoms and make BHR worse.

An acute disease is a medical condition that has a rapid onset, develops quickly, and tends to be short in duration. Acute diseases can range from minor illnesses such as a common cold or flu, to more severe conditions such as pneumonia, meningitis, or a heart attack. These types of diseases often have clear symptoms that are easy to identify, and they may require immediate medical attention or treatment.

Acute diseases are typically caused by an external agent or factor, such as a bacterial or viral infection, a toxin, or an injury. They can also be the result of a sudden worsening of an existing chronic condition. In general, acute diseases are distinct from chronic diseases, which are long-term medical conditions that develop slowly over time and may require ongoing management and treatment.

Examples of acute diseases include:

* Acute bronchitis: a sudden inflammation of the airways in the lungs, often caused by a viral infection.
* Appendicitis: an inflammation of the appendix that can cause severe pain and requires surgical removal.
* Gastroenteritis: an inflammation of the stomach and intestines, often caused by a viral or bacterial infection.
* Migraine headaches: intense headaches that can last for hours or days, and are often accompanied by nausea, vomiting, and sensitivity to light and sound.
* Myocardial infarction (heart attack): a sudden blockage of blood flow to the heart muscle, often caused by a buildup of plaque in the coronary arteries.
* Pneumonia: an infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
* Sinusitis: an inflammation of the sinuses, often caused by a viral or bacterial infection.

It's important to note that while some acute diseases may resolve on their own with rest and supportive care, others may require medical intervention or treatment to prevent complications and promote recovery. If you are experiencing symptoms of an acute disease, it is always best to seek medical attention to ensure proper diagnosis and treatment.

Immunoglobulin A (IgA) is a type of antibody that plays a crucial role in the immune function of the human body. It is primarily found in external secretions, such as saliva, tears, breast milk, and sweat, as well as in mucous membranes lining the respiratory and gastrointestinal tracts. IgA exists in two forms: a monomeric form found in serum and a polymeric form found in secretions.

The primary function of IgA is to provide immune protection at mucosal surfaces, which are exposed to various environmental antigens, such as bacteria, viruses, parasites, and allergens. By doing so, it helps prevent the entry and colonization of pathogens into the body, reducing the risk of infections and inflammation.

IgA functions by binding to antigens present on the surface of pathogens or allergens, forming immune complexes that can neutralize their activity. These complexes are then transported across the epithelial cells lining mucosal surfaces and released into the lumen, where they prevent the adherence and invasion of pathogens.

In summary, Immunoglobulin A (IgA) is a vital antibody that provides immune defense at mucosal surfaces by neutralizing and preventing the entry of harmful antigens into the body.

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a laboratory technique used in molecular biology to amplify and detect specific DNA sequences. This technique is particularly useful for the detection and quantification of RNA viruses, as well as for the analysis of gene expression.

The process involves two main steps: reverse transcription and polymerase chain reaction (PCR). In the first step, reverse transcriptase enzyme is used to convert RNA into complementary DNA (cDNA) by reading the template provided by the RNA molecule. This cDNA then serves as a template for the PCR amplification step.

In the second step, the PCR reaction uses two primers that flank the target DNA sequence and a thermostable polymerase enzyme to repeatedly copy the targeted cDNA sequence. The reaction mixture is heated and cooled in cycles, allowing the primers to anneal to the template, and the polymerase to extend the new strand. This results in exponential amplification of the target DNA sequence, making it possible to detect even small amounts of RNA or cDNA.

RT-PCR is a sensitive and specific technique that has many applications in medical research and diagnostics, including the detection of viruses such as HIV, hepatitis C virus, and SARS-CoV-2 (the virus that causes COVID-19). It can also be used to study gene expression, identify genetic mutations, and diagnose genetic disorders.

"Specific Pathogen-Free (SPF)" is a term used to describe animals or organisms that are raised and maintained in a controlled environment, free from specific pathogens (disease-causing agents) that could interfere with research outcomes or pose a risk to human or animal health. The "specific" part of the term refers to the fact that the exclusion of pathogens is targeted to those that are relevant to the particular organism or research being conducted.

To maintain an SPF status, animals are typically housed in specialized facilities with strict biosecurity measures, such as air filtration systems, quarantine procedures, and rigorous sanitation protocols. They are usually bred and raised in isolation from other animals, and their health status is closely monitored to ensure that they remain free from specific pathogens.

It's important to note that SPF does not necessarily mean "germ-free" or "sterile," as some microorganisms may still be present in the environment or on the animals themselves, even in an SPF facility. Instead, it means that the animals are free from specific pathogens that have been identified and targeted for exclusion.

In summary, Specific Pathogen-Free Organisms refer to animals or organisms that are raised and maintained in a controlled environment, free from specific disease-causing agents that are relevant to the research being conducted or human/animal health.

CD8-positive T-lymphocytes, also known as CD8+ T cells or cytotoxic T cells, are a type of white blood cell that plays a crucial role in the adaptive immune system. They are named after the CD8 molecule found on their surface, which is a protein involved in cell signaling and recognition.

CD8+ T cells are primarily responsible for identifying and destroying virus-infected cells or cancerous cells. When activated, they release cytotoxic granules that contain enzymes capable of inducing apoptosis (programmed cell death) in the target cells. They also produce cytokines such as interferon-gamma, which can help coordinate the immune response and activate other immune cells.

CD8+ T cells are generated in the thymus gland and are a type of T cell, which is a lymphocyte that matures in the thymus and plays a central role in cell-mediated immunity. They recognize and respond to specific antigens presented on the surface of infected or cancerous cells in conjunction with major histocompatibility complex (MHC) class I molecules.

Overall, CD8+ T cells are an essential component of the immune system's defense against viral infections and cancer.

Th2 cells, or T helper 2 cells, are a type of CD4+ T cell that plays a key role in the immune response to parasites and allergens. They produce cytokines such as IL-4, IL-5, IL-13 which promote the activation and proliferation of eosinophils, mast cells, and B cells, leading to the production of antibodies such as IgE. Th2 cells also play a role in the pathogenesis of allergic diseases such as asthma, atopic dermatitis, and allergic rhinitis.

It's important to note that an imbalance in Th1/Th2 response can lead to immune dysregulation and disease states. For example, an overactive Th2 response can lead to allergic reactions while an underactive Th2 response can lead to decreased ability to fight off parasitic infections.

It's also worth noting that there are other subsets of CD4+ T cells such as Th1, Th17, Treg and others, each with their own specific functions and cytokine production profiles.

Vero cells are a line of cultured kidney epithelial cells that were isolated from an African green monkey (Cercopithecus aethiops) in the 1960s. They are named after the location where they were initially developed, the Vervet Research Institute in Japan.

Vero cells have the ability to divide indefinitely under certain laboratory conditions and are often used in scientific research, including virology, as a host cell for viruses to replicate. This allows researchers to study the characteristics of various viruses, such as their growth patterns and interactions with host cells. Vero cells are also used in the production of some vaccines, including those for rabies, polio, and Japanese encephalitis.

It is important to note that while Vero cells have been widely used in research and vaccine production, they can still have variations between different cell lines due to factors like passage number or culture conditions. Therefore, it's essential to specify the exact source and condition of Vero cells when reporting experimental results.

Interleukin-13 (IL-13) is a cytokine that plays a crucial role in the immune response, particularly in the development of allergic inflammation and hypersensitivity reactions. It is primarily produced by activated Th2 cells, mast cells, basophils, and eosinophils. IL-13 mediates its effects through binding to the IL-13 receptor complex, which consists of the IL-13Rα1 and IL-4Rα chains.

IL-13 has several functions in the body, including:

* Regulation of IgE production by B cells
* Induction of eosinophil differentiation and activation
* Inhibition of proinflammatory cytokine production by macrophages
* Promotion of mucus production and airway hyperresponsiveness in the lungs, contributing to the pathogenesis of asthma.

Dysregulation of IL-13 has been implicated in various diseases, such as allergic asthma, atopic dermatitis, and chronic rhinosinusitis. Therefore, targeting IL-13 with biologic therapies has emerged as a promising approach for the treatment of these conditions.

Passive immunization is a type of temporary immunity that is transferred to an individual through the injection of antibodies produced outside of the body, rather than through the active production of antibodies in the body in response to vaccination or infection. This can be done through the administration of preformed antibodies, such as immune globulins, which contain a mixture of antibodies that provide immediate protection against specific diseases.

Passive immunization is often used in situations where individuals have been exposed to a disease and do not have time to develop their own active immune response, or in cases where individuals are unable to produce an adequate immune response due to certain medical conditions. It can also be used as a short-term measure to provide protection until an individual can receive a vaccination that will confer long-term immunity.

Passive immunization provides immediate protection against disease, but the protection is typically short-lived, lasting only a few weeks or months. This is because the transferred antibodies are gradually broken down and eliminated by the body over time. In contrast, active immunization confers long-term immunity through the production of memory cells that can mount a rapid and effective immune response upon re-exposure to the same pathogen in the future.

Respirovirus is not typically used as a formal medical term in modern taxonomy. However, historically, it was used to refer to a genus of viruses within the family Paramyxoviridae, order Mononegavirales. This genus included several important human and animal pathogens that cause respiratory infections.

Human respiroviruses include:
1. Human parainfluenza virus (HPIV) types 1, 2, and 3: These viruses are a common cause of upper and lower respiratory tract infections, such as croup, bronchitis, and pneumonia, particularly in young children.
2. Sendai virus (also known as murine respirovirus): This virus primarily infects rodents but can occasionally cause mild respiratory illness in humans, especially those who work closely with these animals.

The term "respirovirus" is not officially recognized by the International Committee on Taxonomy of Viruses (ICTV) anymore, and these viruses are now classified under different genera within the subfamily Pneumovirinae: Human parainfluenza viruses 1 and 3 belong to the genus Orthorubulavirus, while Human parainfluenza virus 2 is placed in the genus Metapneumovirus.

Chemokines are a family of small cytokines, or signaling proteins, that are secreted by cells and play an important role in the immune system. They are chemotactic, meaning they can attract and guide the movement of various immune cells to specific locations within the body. Chemokines do this by binding to G protein-coupled receptors on the surface of target cells, initiating a signaling cascade that leads to cell migration.

There are four main subfamilies of chemokines, classified based on the arrangement of conserved cysteine residues near the amino terminus: CXC, CC, C, and CX3C. Different chemokines have specific roles in inflammation, immune surveillance, hematopoiesis, and development. Dysregulation of chemokine function has been implicated in various diseases, including autoimmune disorders, infections, and cancer.

In summary, Chemokines are a group of signaling proteins that play a crucial role in the immune system by directing the movement of immune cells to specific locations within the body, thus helping to coordinate the immune response.

Murine pneumonia virus (MPV) is not a widely recognized or officially established medical term. However, it may refer to the Pneumonia Virus of Mice (PVM), which is a pathogen that affects mice and can cause interstitial pneumonia.

PVM is an enveloped, single-stranded, negative-sense RNA virus belonging to the family Paramyxoviridae and the genus Pneumovirus. It primarily infects laboratory mice but has also been found in wild mouse populations. The virus replicates in the respiratory epithelium, leading to interstitial pneumonia and inflammation of the airways.

It is essential to note that Murine Pneumonia Virus should not be confused with Hantavirus Pulmonary Syndrome (HPS), which is also known as "mouse-related pulmonary syndrome." HPS is a severe, sometimes fatal, respiratory disease in humans caused by exposure to hantaviruses, which are found in rodents.

"Bronchi" are a pair of airways in the respiratory system that branch off from the trachea (windpipe) and lead to the lungs. They are responsible for delivering oxygen-rich air to the lungs and removing carbon dioxide during exhalation. The right bronchus is slightly larger and more vertical than the left, and they further divide into smaller branches called bronchioles within the lungs. Any abnormalities or diseases affecting the bronchi can impact lung function and overall respiratory health.

A viral vaccine is a biological preparation that introduces your body to a specific virus in a way that helps your immune system build up protection against the virus without causing the illness. Viral vaccines can be made from weakened or inactivated forms of the virus, or parts of the virus such as proteins or sugars. Once introduced to the body, the immune system recognizes the virus as foreign and produces an immune response, including the production of antibodies. These antibodies remain in the body and provide immunity against future infection with that specific virus.

Viral vaccines are important tools for preventing infectious diseases caused by viruses, such as influenza, measles, mumps, rubella, polio, hepatitis A and B, rabies, rotavirus, chickenpox, shingles, and some types of cancer. Vaccination programs have led to the control or elimination of many infectious diseases that were once common.

It's important to note that viral vaccines are not effective against bacterial infections, and separate vaccines must be developed for each type of virus. Additionally, because viruses can mutate over time, it is necessary to update some viral vaccines periodically to ensure continued protection.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

'Cercopithecus aethiops' is the scientific name for the monkey species more commonly known as the green monkey. It belongs to the family Cercopithecidae and is native to western Africa. The green monkey is omnivorous, with a diet that includes fruits, nuts, seeds, insects, and small vertebrates. They are known for their distinctive greenish-brown fur and long tail. Green monkeys are also important animal models in biomedical research due to their susceptibility to certain diseases, such as SIV (simian immunodeficiency virus), which is closely related to HIV.

Virus shedding refers to the release of virus particles by an infected individual, who can then transmit the virus to others through various means such as respiratory droplets, fecal matter, or bodily fluids. This occurs when the virus replicates inside the host's cells and is released into the surrounding environment, where it can infect other individuals. The duration of virus shedding varies depending on the specific virus and the individual's immune response. It's important to note that some individuals may shed viruses even before they show symptoms, making infection control measures such as hand hygiene, mask-wearing, and social distancing crucial in preventing the spread of infectious diseases.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Orthomyxoviridae is a family of viruses that includes influenza A, B, and C viruses, which are the causative agents of flu in humans and animals. These viruses are enveloped, meaning they have a lipid membrane derived from the host cell, and have a single-stranded, negative-sense RNA genome. The genome is segmented, meaning it consists of several separate pieces of RNA, which allows for genetic reassortment or "shuffling" when two different strains infect the same cell, leading to the emergence of new strains.

The viral envelope contains two major glycoproteins: hemagglutinin (HA) and neuraminidase (NA). The HA protein is responsible for binding to host cells and facilitating entry into the cell, while NA helps release newly formed virus particles from infected cells by cleaving sialic acid residues on the host cell surface.

Orthomyxoviruses are known to cause respiratory infections in humans and animals, with influenza A viruses being the most virulent and capable of causing pandemics. Influenza B viruses typically cause less severe illness and are primarily found in humans, while influenza C viruses generally cause mild upper respiratory symptoms and are also mainly restricted to humans.

Monoclonal antibodies are laboratory-produced proteins that mimic the immune system's ability to fight off harmful antigens such as viruses and cancer cells. They are created by fusing a single B cell (the type of white blood cell responsible for producing antibodies) with a tumor cell, resulting in a hybrid cell called a hybridoma. This hybridoma can then be cloned to produce a large number of identical cells, all producing the same antibody, hence "monoclonal."

Humanized monoclonal antibodies are a type of monoclonal antibody that have been genetically engineered to include human components. This is done to reduce the risk of an adverse immune response in patients receiving the treatment. In this process, the variable region of the mouse monoclonal antibody, which contains the antigen-binding site, is grafted onto a human constant region. The resulting humanized monoclonal antibody retains the ability to bind to the target antigen while minimizing the immunogenicity associated with murine (mouse) antibodies.

In summary, "antibodies, monoclonal, humanized" refers to a type of laboratory-produced protein that mimics the immune system's ability to fight off harmful antigens, but with reduced immunogenicity due to the inclusion of human components in their structure.

Parainfluenza Virus 3, Bovine (PIV-3, Bovine) is a species-specific virus that belongs to the family Paramyxoviridae and genus Respirovirus. It primarily infects cattle and is one of the major causes of respiratory illness in young calves, known as bovine respiratory disease complex (BRDC). The virus is transmitted through direct contact with infected animals or contaminated fomites and mainly affects the upper and lower respiratory tract.

The Bovine Parainfluenza Virus 3 has a single-stranded, negative-sense RNA genome that encodes for several structural and non-structural proteins. The viral envelope contains two glycoprotein spikes: the hemagglutinin-neuraminidase (HN) protein and the fusion (F) protein. These proteins play crucial roles in the attachment, fusion, and entry of the virus into the host cell.

Clinical signs of Bovine Parainfluenza Virus 3 infection include coughing, nasal discharge, fever, difficulty breathing, and reduced appetite. In severe cases, it can lead to pneumonia, which may result in significant economic losses for the cattle industry. Although vaccines are available to control the spread of this virus, they might not always prevent infection or transmission but can help reduce the severity of clinical signs and minimize the impact on animal health and productivity.

Pneumovirus infections refer to respiratory illnesses caused by viruses belonging to the Pneumoviridae family, specifically human respirovirus (hRSV) and human metapneumovirus (hMPV). These viruses primarily infect the respiratory tract and can cause a wide range of symptoms, from mild upper respiratory tract infections to severe lower respiratory tract illnesses such as bronchiolitis and pneumonia.

Human respirovirus (hRSV) is a leading cause of bronchiolitis and pneumonia in infants and young children, while human metapneumovirus (hMPV) tends to infect older children and adults, causing similar respiratory symptoms. Both viruses can also cause more severe disease in immunocompromised individuals, the elderly, and those with underlying medical conditions.

Transmission of these viruses typically occurs through close contact with infected individuals or contaminated surfaces, and they are highly contagious. Preventive measures include good hygiene practices, such as frequent handwashing and avoiding close contact with sick individuals. Currently, there are no vaccines available to prevent pneumovirus infections, but antiviral treatments and supportive care can help manage the symptoms and reduce the risk of complications.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

A virus is a small infectious agent that replicates inside the living cells of an organism. It is not considered to be a living organism itself, as it lacks the necessary components to independently maintain its own metabolic functions. Viruses are typically composed of genetic material, either DNA or RNA, surrounded by a protein coat called a capsid. Some viruses also have an outer lipid membrane known as an envelope.

Viruses can infect all types of organisms, from animals and plants to bacteria and archaea. They cause various diseases by invading the host cell, hijacking its machinery, and using it to produce numerous copies of themselves, which can then infect other cells. The resulting infection and the immune response it triggers can lead to a range of symptoms, depending on the virus and the host organism.

Viruses are transmitted through various means, such as respiratory droplets, bodily fluids, contaminated food or water, and vectors like insects. Prevention methods include vaccination, practicing good hygiene, using personal protective equipment, and implementing public health measures to control their spread.

A Cytopathic Effect (CPE) is a visible change in the cell or group of cells due to infection by a pathogen, such as a virus. When the cytopathic effect is caused specifically by a viral infection, it is referred to as a "Viral Cytopathic Effect" (VCPE).

The VCPE can include various changes in the cell's morphology, size, and structure, such as rounding, shrinkage, multinucleation, inclusion bodies, and formation of syncytia (multinucleated giant cells). These changes are often used to identify and characterize viruses in laboratory settings.

The VCPE is typically observed under a microscope after the virus has infected cell cultures, and it can help researchers determine the type of virus, the degree of infection, and the effectiveness of antiviral treatments. The severity and timing of the VCPE can vary depending on the specific virus and the type of cells that are infected.

Virology is the study of viruses, their classification, and their effects on living organisms. It involves the examination of viral genetic material, viral replication, how viruses cause disease, and the development of antiviral drugs and vaccines to treat or prevent virus infections. Virologists study various types of viruses that can infect animals, plants, and microorganisms, as well as understand their evolution and transmission patterns.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Pneumovirus is a genus of viruses in the family Pneumoviridae, order Mononegavirales. It includes several species that can cause respiratory infections in humans and animals. The most well-known species that infect humans is Human Respiratory Syncytial Virus (HRSV), which is a major cause of bronchiolitis and pneumonia in young children, the elderly, and immunocompromised individuals. Other human pneumoviruses include Human Metapneumovirus (HMPV) and Avian Metapneumovirus subtype C (AMPV-C). These viruses can cause similar respiratory symptoms, ranging from mild to severe.

Pneumoviruses are enveloped, negative-sense, single-stranded RNA viruses that replicate in the cytoplasm of infected cells. They have a nonsegmented genome and encode several structural proteins, including an attachment protein, fusion protein, matrix protein, and nucleocapsid protein. The virions are typically pleomorphic, with a diameter of 150-250 nm.

Transmission of pneumoviruses occurs through respiratory droplets or direct contact with contaminated surfaces. Preventive measures include good hygiene practices, such as hand washing and covering the mouth and nose when coughing or sneezing. There are currently no vaccines available for human pneumoviruses, but several candidates are in development. Treatment is primarily supportive and may include oxygen therapy, mechanical ventilation, and antiviral medications in severe cases.

Parainfluenza Virus 1, Human (HPIV-1) is a type of respiratory virus that belongs to the family Paramyxoviridae and genus Respirovirus. It is one of the four serotypes of human parainfluenza viruses (HPIVs), which are important causes of acute respiratory infections in children, immunocompromised individuals, and the elderly.

HPIV-1 primarily infects the upper respiratory tract, causing symptoms such as cough, runny nose, sore throat, and fever. However, it can also cause lower respiratory tract infections, including bronchitis, bronchiolitis, and pneumonia, particularly in young children and infants.

HPIV-1 is transmitted through respiratory droplets or direct contact with infected individuals. The incubation period for HPIV-1 infection ranges from 2 to 7 days, after which symptoms can last for up to 10 days. There is no specific antiviral treatment available for HPIV-1 infections, and management typically involves supportive care such as hydration, fever reduction, and respiratory support if necessary.

Prevention measures include good hand hygiene, avoiding close contact with infected individuals, and practicing cough etiquette. Vaccines are not currently available for HPIV-1 infections, but research is ongoing to develop effective vaccines against these viruses.

CD4-positive T-lymphocytes, also known as CD4+ T cells or helper T cells, are a type of white blood cell that plays a crucial role in the immune response. They express the CD4 receptor on their surface and help coordinate the immune system's response to infectious agents such as viruses and bacteria.

CD4+ T cells recognize and bind to specific antigens presented by antigen-presenting cells, such as dendritic cells or macrophages. Once activated, they can differentiate into various subsets of effector cells, including Th1, Th2, Th17, and Treg cells, each with distinct functions in the immune response.

CD4+ T cells are particularly important in the immune response to HIV (human immunodeficiency virus), which targets and destroys these cells, leading to a weakened immune system and increased susceptibility to opportunistic infections. The number of CD4+ T cells is often used as a marker of disease progression in HIV infection, with lower counts indicating more advanced disease.

A viral plaque assay is a laboratory technique used to measure the infectivity and concentration of viruses in a sample. This method involves infecting a monolayer of cells (usually in a petri dish or multi-well plate) with a known volume of a virus-containing sample, followed by overlaying the cells with a nutrient-agar medium to restrict viral spread and enable individual plaques to form.

After an incubation period that allows for viral replication and cell death, the cells are stained, and clear areas or "plaques" become visible in the monolayer. Each plaque represents a localized region of infected and lysed cells, caused by the progeny of a single infectious virus particle. The number of plaques is then counted, and the viral titer (infectious units per milliliter or PFU/mL) is calculated based on the dilution factor and volume of the original inoculum.

Viral plaque assays are essential for determining viral titers, assessing virus-host interactions, evaluating antiviral agents, and studying viral pathogenesis.

'Influenza A Virus, H1N1 Subtype' is a specific subtype of the influenza A virus that causes flu in humans and animals. It contains certain proteins called hemagglutinin (H) and neuraminidase (N) on its surface, with this subtype specifically having H1 and N1 antigens. The H1N1 strain is well-known for causing the 2009 swine flu pandemic, which was a global outbreak of flu that resulted in significant morbidity and mortality. This subtype can also cause seasonal flu, although the severity and symptoms may vary. It is important to note that influenza viruses are constantly changing, and new strains or subtypes can emerge over time, requiring regular updates to vaccines to protect against them.

Virus receptors are specific molecules (commonly proteins) on the surface of host cells that viruses bind to in order to enter and infect those cells. This interaction between the virus and its receptor is a critical step in the infection process. Different types of viruses have different receptor requirements, and identifying these receptors can provide important insights into the biology of the virus and potential targets for antiviral therapies.

Attenuated vaccines consist of live microorganisms that have been weakened (attenuated) through various laboratory processes so they do not cause disease in the majority of recipients but still stimulate an immune response. The purpose of attenuation is to reduce the virulence or replication capacity of the pathogen while keeping it alive, allowing it to retain its antigenic properties and induce a strong and protective immune response.

Examples of attenuated vaccines include:

1. Sabin oral poliovirus vaccine (OPV): This vaccine uses live but weakened polioviruses to protect against all three strains of the disease-causing poliovirus. The weakened viruses replicate in the intestine and induce an immune response, which provides both humoral (antibody) and cell-mediated immunity.
2. Measles, mumps, and rubella (MMR) vaccine: This combination vaccine contains live attenuated measles, mumps, and rubella viruses. It is given to protect against these three diseases and prevent their spread in the population.
3. Varicella (chickenpox) vaccine: This vaccine uses a weakened form of the varicella-zoster virus, which causes chickenpox. By introducing this attenuated virus into the body, it stimulates an immune response that protects against future infection with the wild-type virus.
4. Yellow fever vaccine: This live attenuated vaccine is used to prevent yellow fever, a viral disease transmitted by mosquitoes in tropical and subtropical regions of Africa and South America. The vaccine contains a weakened form of the yellow fever virus that cannot cause the disease but still induces an immune response.
5. Bacillus Calmette-Guérin (BCG) vaccine: This live attenuated vaccine is used to protect against tuberculosis (TB). It contains a weakened strain of Mycobacterium bovis, which does not cause TB in humans but stimulates an immune response that provides some protection against the disease.

Attenuated vaccines are generally effective at inducing long-lasting immunity and can provide robust protection against targeted diseases. However, they may pose a risk for individuals with weakened immune systems, as the attenuated viruses or bacteria could potentially cause illness in these individuals. Therefore, it is essential to consider an individual's health status before administering live attenuated vaccines.

Measles virus is a single-stranded, negative-sense RNA virus belonging to the genus Morbillivirus in the family Paramyxoviridae. It is the causative agent of measles, a highly contagious infectious disease characterized by fever, cough, runny nose, and a red, blotchy rash. The virus primarily infects the respiratory tract and then spreads throughout the body via the bloodstream.

The genome of the measles virus is approximately 16 kilobases in length and encodes for eight proteins: nucleocapsid (N), phosphoprotein (P), matrix protein (M), fusion protein (F), hemagglutinin (H), large protein (L), and two non-structural proteins, V and C. The H protein is responsible for binding to the host cell receptor CD150 (SLAM) and mediating viral entry, while the F protein facilitates fusion of the viral and host cell membranes.

Measles virus is transmitted through respiratory droplets and direct contact with infected individuals. The virus can remain airborne for up to two hours in a closed space, making it highly contagious. Measles is preventable through vaccination, which has led to significant reductions in the incidence of the disease worldwide.

Viral genes refer to the genetic material present in viruses that contains the information necessary for their replication and the production of viral proteins. In DNA viruses, the genetic material is composed of double-stranded or single-stranded DNA, while in RNA viruses, it is composed of single-stranded or double-stranded RNA.

Viral genes can be classified into three categories: early, late, and structural. Early genes encode proteins involved in the replication of the viral genome, modulation of host cell processes, and regulation of viral gene expression. Late genes encode structural proteins that make up the viral capsid or envelope. Some viruses also have structural genes that are expressed throughout their replication cycle.

Understanding the genetic makeup of viruses is crucial for developing antiviral therapies and vaccines. By targeting specific viral genes, researchers can develop drugs that inhibit viral replication and reduce the severity of viral infections. Additionally, knowledge of viral gene sequences can inform the development of vaccines that stimulate an immune response to specific viral proteins.

'Gene expression regulation' refers to the processes that control whether, when, and where a particular gene is expressed, meaning the production of a specific protein or functional RNA encoded by that gene. This complex mechanism can be influenced by various factors such as transcription factors, chromatin remodeling, DNA methylation, non-coding RNAs, and post-transcriptional modifications, among others. Proper regulation of gene expression is crucial for normal cellular function, development, and maintaining homeostasis in living organisms. Dysregulation of gene expression can lead to various diseases, including cancer and genetic disorders.

Virus assembly, also known as virion assembly, is the final stage in the virus life cycle where individual viral components come together to form a complete viral particle or virion. This process typically involves the self-assembly of viral capsid proteins around the viral genome (DNA or RNA) and, in enveloped viruses, the acquisition of a lipid bilayer membrane containing viral glycoproteins. The specific mechanisms and regulation of virus assembly vary among different viral families, but it is often directed by interactions between viral structural proteins and genomic nucleic acid.

Interleukin-4 (IL-4) is a type of cytokine, which is a cell signaling molecule that mediates communication between cells in the immune system. Specifically, IL-4 is produced by activated T cells and mast cells, among other cells, and plays an important role in the differentiation and activation of immune cells called Th2 cells.

Th2 cells are involved in the immune response to parasites, as well as in allergic reactions. IL-4 also promotes the growth and survival of B cells, which produce antibodies, and helps to regulate the production of certain types of antibodies. In addition, IL-4 has anti-inflammatory effects and can help to downregulate the immune response in some contexts.

Defects in IL-4 signaling have been implicated in a number of diseases, including asthma, allergies, and certain types of cancer.

Asthma is a chronic respiratory disease characterized by inflammation and narrowing of the airways, leading to symptoms such as wheezing, coughing, shortness of breath, and chest tightness. The airway obstruction in asthma is usually reversible, either spontaneously or with treatment.

The underlying cause of asthma involves a combination of genetic and environmental factors that result in hypersensitivity of the airways to certain triggers, such as allergens, irritants, viruses, exercise, and emotional stress. When these triggers are encountered, the airways constrict due to smooth muscle spasm, swell due to inflammation, and produce excess mucus, leading to the characteristic symptoms of asthma.

Asthma is typically managed with a combination of medications that include bronchodilators to relax the airway muscles, corticosteroids to reduce inflammation, and leukotriene modifiers or mast cell stabilizers to prevent allergic reactions. Avoiding triggers and monitoring symptoms are also important components of asthma management.

There are several types of asthma, including allergic asthma, non-allergic asthma, exercise-induced asthma, occupational asthma, and nocturnal asthma, each with its own set of triggers and treatment approaches. Proper diagnosis and management of asthma can help prevent exacerbations, improve quality of life, and reduce the risk of long-term complications.

Paramyxoviridae is a family of negative-sense, single-stranded RNA viruses that include several medically important pathogens. These viruses are characterized by their enveloped particles and helical symmetry. The paramyxoviruses can cause respiratory infections, neurological disorders, and other systemic diseases in humans, animals, and birds.

Some notable members of the Paramyxoviridae family include:

* Human respirovirus (also known as human parainfluenza virus): causes upper and lower respiratory tract infections in children and adults.
* Human orthopneumovirus (also known as respiratory syncytial virus, or RSV): a major cause of bronchiolitis and pneumonia in infants and young children.
* Measles morbillivirus: causes measles, a highly contagious viral disease characterized by fever, rash, and cough.
* Mumps virus: causes mumps, an acute infectious disease that primarily affects the salivary glands.
* Hendra virus and Nipah virus: zoonotic paramyxoviruses that can cause severe respiratory and neurological disease in humans and animals.

Effective vaccines are available for some paramyxoviruses, such as measles and mumps, but there are currently no approved vaccines for others, such as RSV and Nipah virus. Antiviral therapies are also limited, with only a few options available for the treatment of severe paramyxovirus infections.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Orthomyxoviridae is a family of viruses that includes influenza A, B, and C viruses, which can cause respiratory infections in humans. Orthomyxoviridae infections are typically characterized by symptoms such as fever, cough, sore throat, runny or stuffy nose, muscle or body aches, headaches, and fatigue.

Influenza A and B viruses can cause seasonal epidemics of respiratory illness that occur mainly during the winter months in temperate climates. Influenza A viruses can also cause pandemics, which are global outbreaks of disease that occur when a new strain of the virus emerges to which there is little or no immunity in the human population.

Influenza C viruses are less common and typically cause milder illness than influenza A and B viruses. They do not cause epidemics and are not usually included in seasonal flu vaccines.

Orthomyxoviridae infections can be prevented through vaccination, good respiratory hygiene (such as covering the mouth and nose when coughing or sneezing), hand washing, and avoiding close contact with sick individuals. Antiviral medications may be prescribed to treat influenza A and B infections, particularly for people at high risk of complications, such as older adults, young children, pregnant women, and people with certain underlying medical conditions.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

T-lymphocytes, also known as T-cells, are a type of white blood cell that plays a key role in the adaptive immune system's response to infection. They are produced in the bone marrow and mature in the thymus gland. There are several different types of T-cells, including CD4+ helper T-cells, CD8+ cytotoxic T-cells, and regulatory T-cells (Tregs).

CD4+ helper T-cells assist in activating other immune cells, such as B-lymphocytes and macrophages. They also produce cytokines, which are signaling molecules that help coordinate the immune response. CD8+ cytotoxic T-cells directly kill infected cells by releasing toxic substances. Regulatory T-cells help maintain immune tolerance and prevent autoimmune diseases by suppressing the activity of other immune cells.

T-lymphocytes are important in the immune response to viral infections, cancer, and other diseases. Dysfunction or depletion of T-cells can lead to immunodeficiency and increased susceptibility to infections. On the other hand, an overactive T-cell response can contribute to autoimmune diseases and chronic inflammation.

The Fluorescent Antibody Technique (FAT), Direct is a type of immunofluorescence assay used in laboratory diagnostic tests. It is a method for identifying and locating specific antigens in cells or tissues by using fluorescent-labeled antibodies that directly bind to the target antigen.

In this technique, a sample (such as a tissue section or cell smear) is prepared and then treated with a fluorescently labeled primary antibody that specifically binds to the antigen of interest. After washing away unbound antibodies, the sample is examined under a fluorescence microscope. If the antigen is present in the sample, it will be visible as distinct areas of fluorescence, allowing for the direct visualization and localization of the antigen within the cells or tissues.

Direct FAT is commonly used in diagnostic laboratories to identify and diagnose various infectious diseases, including bacterial, viral, and fungal infections. It can also be used to detect specific proteins or antigens in research and clinical settings.

Inactivated vaccines, also known as killed or non-live vaccines, are created by using a version of the virus or bacteria that has been grown in a laboratory and then killed or inactivated with chemicals, heat, or radiation. This process renders the organism unable to cause disease, but still capable of stimulating an immune response when introduced into the body.

Inactivated vaccines are generally considered safer than live attenuated vaccines since they cannot revert back to a virulent form and cause illness. However, they may require multiple doses or booster shots to maintain immunity because the immune response generated by inactivated vaccines is not as robust as that produced by live vaccines. Examples of inactivated vaccines include those for hepatitis A, rabies, and influenza (inactivated flu vaccine).

Pulmonary eosinophilia is a condition characterized by an increased number of eosinophils, a type of white blood cell, in the lungs or pulmonary tissues. Eosinophils play a role in the body's immune response to parasites and allergens, but an overabundance can contribute to inflammation and damage in the lungs.

The condition may be associated with various underlying causes, such as:

1. Asthma or allergic bronchopulmonary aspergillosis (ABPA)
2. Eosinophilic lung diseases, like eosinophilic pneumonia or idiopathic hypereosinophilic syndrome
3. Parasitic infections, such as ascariasis or strongyloidiasis
4. Drug reactions, including certain antibiotics and anti-inflammatory drugs
5. Connective tissue disorders, like rheumatoid arthritis or Churg-Strauss syndrome
6. Malignancies, such as lymphoma or leukemia
7. Other less common conditions, like tropical pulmonary eosinophilia or cryptogenic organizing pneumonia

Symptoms of pulmonary eosinophilia can vary but often include cough, shortness of breath, wheezing, and chest discomfort. Diagnosis typically involves a combination of clinical evaluation, imaging studies, and laboratory tests, such as complete blood count (CBC) with differential, bronchoalveolar lavage (BAL), or lung biopsy. Treatment depends on the underlying cause and may include corticosteroids, antibiotics, or antiparasitic medications.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Influenza A virus is defined as a negative-sense, single-stranded, segmented RNA virus belonging to the family Orthomyxoviridae. It is responsible for causing epidemic and pandemic influenza in humans and is also known to infect various animal species, such as birds, pigs, horses, and seals. The viral surface proteins, hemagglutinin (HA) and neuraminidase (NA), are the primary targets for antiviral drugs and vaccines. There are 18 different HA subtypes and 11 known NA subtypes, which contribute to the diversity and antigenic drift of Influenza A viruses. The zoonotic nature of this virus allows for genetic reassortment between human and animal strains, leading to the emergence of novel variants with pandemic potential.

"Newborn animals" refers to the very young offspring of animals that have recently been born. In medical terminology, newborns are often referred to as "neonates," and they are classified as such from birth until about 28 days of age. During this time period, newborn animals are particularly vulnerable and require close monitoring and care to ensure their survival and healthy development.

The specific needs of newborn animals can vary widely depending on the species, but generally, they require warmth, nutrition, hydration, and protection from harm. In many cases, newborns are unable to regulate their own body temperature or feed themselves, so they rely heavily on their mothers for care and support.

In medical settings, newborn animals may be examined and treated by veterinarians to ensure that they are healthy and receiving the care they need. This can include providing medical interventions such as feeding tubes, antibiotics, or other treatments as needed to address any health issues that arise. Overall, the care and support of newborn animals is an important aspect of animal medicine and conservation efforts.

"Influenza A Virus, H3N2 Subtype" is a specific subtype of the influenza A virus that causes respiratory illness and is known to circulate in humans and animals, including birds and pigs. The "H3N2" refers to the two proteins on the surface of the virus: hemagglutinin (H) and neuraminidase (N). In this subtype, the H protein is of the H3 variety and the N protein is of the N2 variety. This subtype has been responsible for several influenza epidemics and pandemics in humans, including the 1968 Hong Kong flu pandemic. It is one of the influenza viruses that are monitored closely by public health authorities due to its potential to cause significant illness and death, particularly in high-risk populations such as older adults, young children, and people with certain underlying medical conditions.

Synthetic vaccines are artificially produced, designed to stimulate an immune response and provide protection against specific diseases. Unlike traditional vaccines that are derived from weakened or killed pathogens, synthetic vaccines are created using synthetic components, such as synthesized viral proteins, DNA, or RNA. These components mimic the disease-causing agent and trigger an immune response without causing the actual disease. The use of synthetic vaccines offers advantages in terms of safety, consistency, and scalability in production, making them valuable tools for preventing infectious diseases.

A "knockout" mouse is a genetically engineered mouse in which one or more genes have been deleted or "knocked out" using molecular biology techniques. This allows researchers to study the function of specific genes and their role in various biological processes, as well as potential associations with human diseases. The mice are generated by introducing targeted DNA modifications into embryonic stem cells, which are then used to create a live animal. Knockout mice have been widely used in biomedical research to investigate gene function, disease mechanisms, and potential therapeutic targets.

A disease outbreak is defined as the occurrence of cases of a disease in excess of what would normally be expected in a given time and place. It may affect a small and localized group or a large number of people spread over a wide area, even internationally. An outbreak may be caused by a new agent, a change in the agent's virulence or host susceptibility, or an increase in the size or density of the host population.

Outbreaks can have significant public health and economic impacts, and require prompt investigation and control measures to prevent further spread of the disease. The investigation typically involves identifying the source of the outbreak, determining the mode of transmission, and implementing measures to interrupt the chain of infection. This may include vaccination, isolation or quarantine, and education of the public about the risks and prevention strategies.

Examples of disease outbreaks include foodborne illnesses linked to contaminated food or water, respiratory infections spread through coughing and sneezing, and mosquito-borne diseases such as Zika virus and West Nile virus. Outbreaks can also occur in healthcare settings, such as hospitals and nursing homes, where vulnerable populations may be at increased risk of infection.

RNA virus infections refer to diseases or conditions caused by the invasion and replication of RNA (Ribonucleic acid) viruses in host cells. These viruses use RNA as their genetic material, which is different from DNA (Deoxyribonucleic acid) viruses. Upon entering a host cell, the RNA virus releases its genetic material, which then uses the host cell's machinery to produce new viral components and replicate. This process can lead to various outcomes, depending on the specific virus and the host's immune response:

1. Asymptomatic infection: Some RNA virus infections may not cause any noticeable symptoms and may only be discovered through diagnostic testing.
2. Acute infection: Many RNA viruses cause acute infections, characterized by the rapid onset of symptoms that typically last for a short period (days to weeks). Examples include the common cold (caused by rhinoviruses), influenza (caused by orthomyxoviruses), and some gastrointestinal infections (caused by noroviruses or rotaviruses).
3. Chronic infection: A few RNA viruses can establish chronic infections, where the virus persists in the host for an extended period, sometimes leading to long-term health complications. Examples include HIV (Human Immunodeficiency Virus), HCV (Hepatitis C Virus), and HTLV-1 (Human T-lymphotropic virus type 1).
4. Latent infection: Some RNA viruses, like herpesviruses, can establish latency in the host, where they remain dormant for extended periods but can reactivate under certain conditions, causing recurrent symptoms or diseases.
5. Oncogenic potential: Certain RNA viruses have oncogenic properties and can contribute to the development of cancer. For example, retroviruses like HTLV-1 can cause leukemia and lymphoma by integrating their genetic material into the host cell's DNA and altering gene expression.

Treatment for RNA virus infections varies depending on the specific virus and the severity of the infection. Antiviral medications, immunotherapy, and supportive care are common treatment strategies. Vaccines are also available to prevent some RNA virus infections, such as measles, mumps, rubella, influenza, and hepatitis A and B.

"Influenza A Virus, H5N1 Subtype" is a specific subtype of the Influenza A virus that is often found in avian species (birds) and can occasionally infect humans. The "H5N1" refers to the specific proteins (hemagglutinin and neuraminidase) found on the surface of the virus. This subtype has caused serious infections in humans, with high mortality rates, especially in cases where people have had close contact with infected birds. It does not commonly spread from person to person, but there is concern that it could mutate and adapt to efficiently transmit between humans, which would potentially cause a pandemic.

A plant virus is not defined in medical terms, as viruses are typically considered within the context of living organisms and plants are not classified as such. However, I can provide a general virology definition for you:

Plant viruses are small infectious agents that consist of nucleic acid (DNA or RNA) enclosed in a protein coat. They infect various plant species, causing a wide range of symptoms and diseases, which can result in significant economic losses in agriculture and horticulture. Plant viruses lack the ability to replicate outside a host cell, and they rely on the host's metabolic machinery for their reproduction. They can be transmitted through various means, such as insect vectors, seeds, or mechanical contact.

Sendai virus, also known as murine parainfluenza virus or pneumonia virus of mice, is a species of paramyxovirus that primarily infects rodents. It is an enveloped, negative-sense, single-stranded RNA virus with a nonsegmented genome. The virus is named after the city of Sendai in Japan where it was first isolated in 1952.

Sendai virus is highly contagious and can cause respiratory illness in mice, rats, and other small rodents. It replicates in the respiratory epithelium, leading to inflammation and necrosis of the airways. The virus can also suppress the host's immune response, making infected animals more susceptible to secondary bacterial infections.

In laboratory settings, Sendai virus is sometimes used as a tool for studying viral pathogenesis, immunology, and gene therapy. It has been used as a vector for delivering genes into mammalian cells, including human cells, due to its ability to efficiently infect and transduce a wide range of cell types.

It's important to note that Sendai virus is not known to infect humans or cause disease in humans, and it is not considered a significant public health concern.

Sindbis virus is an alphavirus that belongs to the Togaviridae family. It's named after the location where it was first isolated, in Sindbis, Egypt, in 1952. This virus is primarily transmitted by mosquitoes and can infect a wide range of animals, including birds and humans. In humans, Sindbis virus infection often causes a mild flu-like illness characterized by fever, rash, and joint pain. However, some people may develop more severe symptoms, such as neurological disorders, although this is relatively rare. There is no specific treatment for Sindbis virus infection, and management typically involves supportive care to alleviate symptoms.

DNA viruses are a type of virus that contain DNA (deoxyribonucleic acid) as their genetic material. These viruses replicate by using the host cell's machinery to synthesize new viral components, which are then assembled into new viruses and released from the host cell.

DNA viruses can be further classified based on the structure of their genomes and the way they replicate. For example, double-stranded DNA (dsDNA) viruses have a genome made up of two strands of DNA, while single-stranded DNA (ssDNA) viruses have a genome made up of a single strand of DNA.

Examples of DNA viruses include herpes simplex virus, varicella-zoster virus, human papillomavirus, and adenoviruses. Some DNA viruses are associated with specific diseases, such as cancer (e.g., human papillomavirus) or neurological disorders (e.g., herpes simplex virus).

It's important to note that while DNA viruses contain DNA as their genetic material, RNA viruses contain RNA (ribonucleic acid) as their genetic material. Both DNA and RNA viruses can cause a wide range of diseases in humans, animals, and plants.

Influenza B virus is one of the primary types of influenza viruses that cause seasonal flu in humans. It's an enveloped, negative-sense, single-stranded RNA virus belonging to the family Orthomyxoviridae.

Influenza B viruses are typically found only in humans and circulate widely during the annual flu season. They mutate at a slower rate than Influenza A viruses, which means that immunity developed against one strain tends to provide protection against similar strains in subsequent seasons. However, they can still cause significant illness, especially among young children, older adults, and people with certain chronic medical conditions.

Influenza B viruses are divided into two lineages: Victoria and Yamagata. Vaccines are developed each year to target the most likely strains of Influenza A and B viruses that will circulate in the upcoming flu season.

Viral DNA refers to the genetic material present in viruses that consist of DNA as their core component. Deoxyribonucleic acid (DNA) is one of the two types of nucleic acids that are responsible for storing and transmitting genetic information in living organisms. Viruses are infectious agents much smaller than bacteria that can only replicate inside the cells of other organisms, called hosts.

Viral DNA can be double-stranded (dsDNA) or single-stranded (ssDNA), depending on the type of virus. Double-stranded DNA viruses have a genome made up of two complementary strands of DNA, while single-stranded DNA viruses contain only one strand of DNA.

Examples of dsDNA viruses include Adenoviruses, Herpesviruses, and Poxviruses, while ssDNA viruses include Parvoviruses and Circoviruses. Viral DNA plays a crucial role in the replication cycle of the virus, encoding for various proteins necessary for its multiplication and survival within the host cell.

"Respiratory Syncytial Virus Infection (RSV)". Centers for Disease Control and Prevention. Retrieved 2019-06-03. McIntosh, K. M ... human respiratory syncytial virus •Bos primigenius: bovine respiratory syncytial virus •Rodentia: murine pneumonia virus Mild ... Human respiratory syncytial virus (HRSV) is the most known orthopneumovirus because of its direct correlation and importance in ... ISBN 978-0-88167-552-8. Collins, Peter L. (1991). "The Molecular Biology of Human Respiratory Syncytial Virus (RSV) of the ...
Linda G. Byrd; Gregory A. Prince (December 1997). "Animal Models of Respiratory Syncytial Virus Infection". Clinical Infectious ... Val G. Hemming; Gregory A. Prince (May-June 1990). "Immunoprophylaxis of Infections with Respiratory Syncytial Virus: ... "Resistance to Human Respiratory Syncytial Virus (RSV) Infection Induced by Immunization of Cotton Rats with a Recombinant ... "Pulmonary Lesions in Primary Respiratory Syncytial Virus Infection, Reinfection, and Vaccine-Enhanced Disease in the Cotton Rat ...
CDC (2023-03-16). "Learn about Respiratory Syncytial Virus Infection (RSV)". Centers for Disease Control and Prevention. ... Lactoferrin in HBM can also inhibit the invasion and proliferation of respiratory syncytial virus (RSV), which is a virus ... Lactoferrin can prevent infection of adenovirus since it can interfere with the primary receptors of the virus. HBM ... Adenovirus is another group of viruses that targets the mucosal membrane of the human respiratory tract. It usually causes mild ...
... for the prevention of respiratory syncytial virus infection in high-risk infants. As of September 2009[update], it is ... "Pharmacological management of human respiratory syncytial virus infection". Expert Opinion on Pharmacotherapy. 21 (18): 2293- ... The company stated that it would no longer develop Motavizumab for the prevention of respiratory syncytial virus (RSV), and as ...
... including the respiratory syncytial virus. One study suggests that cellular heparan sulfate has a role in SARS-CoV-2 Infection ... "Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection". Journal of Virology. 74 (22): 10508-13. ... October 1999). "A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry". Cell. 99 (1): 13-22. doi: ... 14 September 2020). "SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2". The Journal of Cell. 183 (4): 1043- ...
Broor, S; Parveen, S; Maheshwari, M (2018). "Respiratory syncytial virus infections in India: Epidemiology and need for vaccine ... Cases of respiratory syncytial virus (RSV) in India mainly occur in North India in the winter. This virus causes lower ... When tourists do get an infection in India, often that infection could have been prevented with a vaccine. The World Health ... respiratory tract infection. India, like many other countries, uses the World Health Organization system for reporting and ...
Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended. Clin Infect Dis 2000;31(2):590-6. CDC. Acute ... Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986;315(2):77-81. Lui SL, Luk ... Modes of transmission of respiratory syncytial virus. J Pediatr 1981;99(1):100-3. Evans MR, Meldrum R, Lane W, et al. An ... J Pediatr 2005;146(4):523-7. Wood DJ, David TJ, Chrystie IL, Totterdell B. Chronic enteric virus infection in two T-cell ...
"Increased concordance of severe respiratory syncytial virus infection in identical twins". Pediatrics. 121 (3): 493-6. doi: ...
"Use of Ribavirin in the Treatment of Respiratory Syncytial Virus Infection". Pediatrics. 92 (3): 501-504. doi:10.1542/peds.92.3 ... was approved under the name Virazole by the Food and Drug Administration for the treatment of respiratory syncytial virus (RSV ... "Press Announcements - FDA approves first test to confirm the presence of Human T-cell Lymphotropic Virus-I/II antibodies". www. ... an upper respiratory tract disease that primarily affects children. In 1991, ICN created the SPAG-2 (Small Particle Aerosol ...
A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine which protects against infection by respiratory syncytial ... "Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus- ... "First vaccine to protect older adults from respiratory syncytial virus (RSV) infection". European Medicines Agency (EMA) (Press ... Respiratory syncytial virus vaccine is indicated for active immunization for the prevention of lower respiratory tract disease ...
Respiratory syncytial virus (RSV) is a very common, contagious virus that causes infections of the respiratory tract. RSV is ... Griffiths C, Drews SJ, Marchant DJ (January 2017). "Respiratory Syncytial Virus: Infection, Detection, and New Options for ... Coultas JA, Smyth R, Openshaw PJ (October 2019). "Respiratory syncytial virus (RSV): a scourge from infancy to old age". Thorax ... PMID 33864736.{{cite journal}}: CS1 maint: multiple names: authors list (link) "FDA Approves First Respiratory Syncytial Virus ...
Acute bronchiolitis is usually the result of infection by respiratory syncytial virus (72% of cases) or human rhinovirus (26% ... "Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection". The Cochrane ... This is most commonly caused by respiratory syncytial virus (RSV, also known as human pneumovirus). Other agents that cause ... Carbonell-Estrany X, Figueras-Aloy J, Law BJ (November 2004). "Identifying risk factors for severe respiratory syncytial virus ...
"New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection". European Medicines Agency (EMA) ( ... "Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus- ... In the European Union, nirsevimab is indicated for the prevention of respiratory syncytial virus RSV lower respiratory tract ... is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV). It is a respiratory ...
"Bovine respiratory syncytial virus infection enhances Pasteurella multocida adherence on respiratory epithelial cells". ... Bovine respiratory syncytial virus (BRSV) is pneumovirus closely related to human respiratory syncytial virus (RSV) that is a ... "Review on bovine respiratory syncytial virus and bovine parainfluenza - usual suspects in bovine respiratory disease - a ... Larsen, L. E. (2000-03-01). "Bovine Respiratory Syncytial Virus (BRSV): A review". Acta Veterinaria Scandinavica. 41 (1): 1-24 ...
Associated viral infections include respiratory syncytial virus, canine distemper virus, and the measles virus. However, recent ... "Immunohistological demonstration of respiratory syncytial virus antigens in Paget disease of bone". Proceedings of the National ... Paget's disease may be caused by a slow virus infection (i.e., paramyxoviridae) present for many years before symptoms appear. ... However, no infectious virus has yet been isolated as a causative agent, and other evidence suggests an intrinsic ...
Diseases of the bronchioles include asthma, bronchiolitis obliterans, respiratory syncytial virus infections, and influenza. ... They include the terminal bronchioles, and finally the respiratory bronchioles that mark the start of the respiratory zone ... Terminal bronchioles mark the end of the conducting division of air flow in the respiratory system while respiratory ... Alveolar ducts are side branches of the respiratory bronchioles. The respiratory bronchioles are lined by ciliated columnar ...
A Review of its Use as Prophylaxis for Serious Respiratory Syncytial Virus Infection". Paediatric Drugs. 6 (3): 177-197. doi: ... which is a humanized monoclonal antibody used as prophylaxis to prevent severe diseases caused by respiratory syncytial virus ( ... the leading cause of lower respiratory tract infections in infants. The drug is recommended for infants with a high risk of RSV ... With proven therapeutic effects, the applications expanded to other viral and bacterial infections, such as pneumococcus, ...
LK Hallak described the importance of this sugar in respiratory syncytial virus (RSV) infection. Dermatan sulfate and heparan ... "Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection". ... sulfate were the only GAGs containing IdoA, and they were the only ones that inhibited RSV infection in cell culture. When ...
These viral respiratory infections are mostly caused by respiratory syncytial virus (RSV) and human rhinovirus (HRV). Although ... In children and adults with established asthma, viral upper respiratory tract infections (URIs), especially HRVs infections, ... There is also a possibility that M. pneumoniae infection may destroy respiratory mucosal cells and facilitate the penetration ... Furthermore, children who experience severe viral respiratory infections early in life have a high possibility of having asthma ...
"Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children". The Cochrane ... Smee DF, Matthews TR (July 1986). "Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells". ... The aerosol form has been used in the past to treat respiratory syncytial virus-related diseases in children, although the ... Paeshuyse J, Dallmeier K, Neyts J (December 2011). "Ribavirin for the treatment of chronic hepatitis C virus infection: a ...
June 2010). "Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and ... April 2009). "Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway ... September 2007). "Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate ... Elevated serum levels of IL-26 were detected in patients with chronic infection by hepatitis C virus. Moreover, the sensitivity ...
... and infections such as HIV/AIDS and respiratory syncytial virus, as well as in cancer. When assayed in the human, the observed ... "Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae". ... Respiratory syncytial and related viruses appear to upregulate SP receptors, and rat studies suggest that NK1RAs may be useful ... The symptoms of infection are diarrhea, constipation, and abdominal pain. This protozoan was found to secrete serotonin as well ...
It is aimed at stimulating resistance to respiratory syncytial virus infection, targeting both adult and infant populations. ... 2016 saw the company's first phase III trial, the 12,000 adult Resolve trial, for its respiratory syncytial virus vaccine, ... Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well ... from the Bill and Melinda Gates Foundation to support the development of a vaccine against human respiratory syncytial virus ...
... of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in ... Some of the diseases tested on the cotton rat are respiratory syncytial virus, and pulmonary tuberculosis, and HIV type-1. In ... A similar immune response to humans is activated on infection. The degree of infection may be increased by altering the co- ... It is affected by many of the same viral and bacterial infections that humans are susceptible to, which helps create vaccines ...
June 2010). "Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and ... March 2010). "Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient ... May 2010). "Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus". The Journal of Infectious ... Bugeon L, Dallman MJ (October 2000). "Costimulation of T cells". American Journal of Respiratory and Critical Care Medicine. ...
2010). "Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls ... 2009). "Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway ... 2009). "Spontaneous preterm birth in African Americans is associated with infection and inflammatory response gene variants". ...
Bruce SR, Atkins CL, Colasurdo GN, Alcorn JL (October 2009). "Respiratory syncytial virus infection alters surfactant protein A ... SP-A has the ability to bind and agglutinate bacteria, fungi, viruses, and other non-biological antigens. Some of the functions ... SP-A2 binds to the carbohydrates found in the surface of several microorganisms and helps in the defense against respiratory ... Pollutants and viral infections also affect SFTPA2 translation mechanisms (see eukaryotic translation, translation (biology)). ...
2003). "Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis ...
2010). "Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls ... 2009). "Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway ... 2007). "Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune ... Nyman TA, Tölö H, Parkkinen J, Kalkkinen N (1998). "Identification of nine interferon-alpha subtypes produced by Sendai virus- ...
Bruce SR, Atkins CL, Colasurdo GN, Alcorn JL (Oct 2009). "Respiratory syncytial virus infection alters surfactant protein A ... SP-A has the ability to bind and agglutinate bacteria, fungi, viruses, and other non-biological antigens. Some of the functions ... SP-A1 binds to the carbohydrates found in the surface of several microorganisms and helps in the defense against respiratory ... Changes in the amount or composition of surfactant can alter its function and are associated with respiratory diseases. The ...
However, repeat infections may occur throughout life, and people of any age can be infected. ... You touch a surface that has the virus on it, like a doorknob, and then touch your face before washing your hands ... However, some infants, and people with weakened immune systems, can continue to spread the virus even after they stop showing ... You get virus droplets from a cough or sneeze in your eyes, nose, or mouth ...
Respiratory Syncytial Virus (RSV) causes cold-like symptoms in adults and healthy children, but can cause serious problems in ... What is respiratory syncytial virus (RSV)?. Respiratory syncytial virus, or RSV, is a common respiratory virus. It usually ... Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for... * Respiratory Syncytial Virus Infections -- see ... Respiratory Syncytial Virus (Nemours Foundation) Also in Spanish * Respiratory Syncytial Virus (RSV) (National Institute of ...
... is the leading cause of lower respiratory tract infections (LRTIs) in infants and young children.{file44441}The clinical entity ... Infection with respiratory syncytial virus (RSV; see the image below), which manifests primarily as bronchiolitis or viral ... encoded search term (Respiratory Syncytial Virus Infection) and Respiratory Syncytial Virus Infection What to Read Next on ... a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection ...
... is the leading cause of lower respiratory tract infections (LRTIs) in infants and young children.{file44441}The clinical entity ... Infection with respiratory syncytial virus (RSV; see the image below), which manifests primarily as bronchiolitis or viral ... encoded search term (Respiratory Syncytial Virus Infection) and Respiratory Syncytial Virus Infection What to Read Next on ... a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection ...
GSK-3888550Ais under clinical development by GSK and currently in Phase III for Respiratory Syncytial Virus (RSV) Infections. ... Infections. According to GlobalData, Phase III drugs for Respiratory Syncytial Virus (RSV) Infections does not have sufficient ... GSK-3888550A by GSK for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval. Brought to you by ... GSK-3888550A is under development for the prevention of respiratory syncytial virus infections. The vaccine candidate is an ...
PF-07960613 is under clinical development by Pfizer and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections. ... Infections. According to GlobalData, Phase II drugs for Respiratory Syncytial Virus (RSV) Infections does not have sufficient ... PF-07960613 by Pfizer for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval. Brought to you by ... PF-07960613 is under development for the prevention of respiratory syncytial virus infection and coronavirus disease 2019 ( ...
... and Human Metapneumovirus Infections - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals ... a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection ... Respiratory syncytial virus and human metapneumovirus infections cause seasonal lower respiratory tract disease, particularly ... 1 Reference Respiratory syncytial virus and human metapneumovirus infections cause seasonal lower respiratory tract disease, ...
A multiplex PCR assay that detects 7 respiratory viruses was used to identify RSV nucleic acid on respiratory specimens. A ... A large percentage of children with RSV infection had pre-existing conditions. Approximately one tenth of the infections were ... is a major cause of lower respiratory tract infection in young children in both the community and hospital setting. The ... RSV group A predominated (n = 181, 80.1 %) while group B accounted for only 45 (19.9 %) of the infections. The ...
Rate of Hospitalizations and Mortality of Respiratory Syncytial Virus Infection Compared to Influenza in Older People: A ...
... is the leading cause of lower respiratory tract infections (LRTIs) in infants and young children.{file44441}The clinical entity ... Infection with respiratory syncytial virus (RSV; see the image below), which manifests primarily as bronchiolitis or viral ... encoded search term (Respiratory Syncytial Virus Infection) and Respiratory Syncytial Virus Infection What to Read Next on ... a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection ...
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and ... Infection by respiratory syncytial virus (RSV) is the most common cause of hospital admission in infants aged less than 1year ... Recommendations of the Spanish Society of Neonatology for the prevention of severe respiratory syncytial virus infections with ... Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004-2012. ...
... syncytial virus infection of BALB/c laboratory mice persisted for up to 7 days after initial infection with peak virus titres ... However, IgG was not detected until day 10 post-infection, 5 days after the initial decline of virus shedding. Virus-specific ... response which was first detectable 6 days after infection and optimal 7 to 9 days after infection. This local CTL response was ... In addition, infection induced rapid interferon production within the lungs which was accompanied by an equally rapid rise in ...
... its ability to accurately identify acute respiratory tract infections (ARTI) caused by RSV in older adults is uncertain. ... Respiratory syncytial virus (RSV) surveillance is heavily dependent on the influenza-like illness (ILI) case definition from ... World Health Organization Influenza-Like Illness Underestimates the Burden of Respiratory Syncytial Virus Infection in ... World Health Organization Influenza-Like Illness Underestimates the Burden of Respiratory Syncytial Virus Infection in ...
Respiratory Syncytial Virus Infections/prevention & Control Respiratory Syncytial Virus Vaccines/economics ... Economics of preventing respiratory syncytial virus lower respiratory tract infections (RSVLRTI) among US infants with ... Economics of preventing respiratory syncytial virus lower respiratory tract infections (RSVLRTI) among US infants with ... Maternal/Pediatric Respiratory Syncytial Virus (RSV) Work Group Cite CITE. Title : Maternal/Pediatric Respiratory Syncytial ...
A repertoire of 382 well-characterized transcriptional modules was used to define dominant host responses to RSV infection. The ... infection are needed. We conducted a meta-analysis of 490 unique profiles from six public RSV blood transcriptome datasets. ... Biomarkers to assess the risk of developing severe respiratory syncytial virus (RSV) ... Biomarkers to assess the risk of developing severe respiratory syncytial virus (RSV) infection are needed. We conducted a meta- ...
Respiratory syncytial virus (RSV) is a frequent cause of acute respiratory infection and the most common cause of bronchiolitis ... Systematic review and meta-analysis of respiratory syncytial virus infection epidemiology in Latin America.. Bardach, Ariel; ... When considering all countries, the largest pooled percentage RSV in low respiratory tract infection patients was found in the ... Infecciones por Virus Sincitial Respiratorio/epidemiología Virus Sincitial Respiratorio Humano/aislamiento & purificación ...
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections and hospitalization in infants ... Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease. ... resulting in virus neutralization. However, in the case of RSV, virus neutralization titers do not provide an adequate ... For protection against infection, young children mainly depend on their innate immune system and maternal antibodies. ...
... infection is identified in epidemiological studies by virus antigen or nucleic acid detection in combination with serology. ... Our data show significant promise for the use of oral fluid alone in RSV infection surveillance. The observed rapid dynamics of ... For a further five young children from whom oral fluid was collected weekly following RSV infection, boosted antibody responses ... and RSV infections were detected by rising titers of antibodies of at least one Ig class. Specific IgG responses were generally ...
... Taylor, Geraldine;Thom, ... Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections / Taylor, Geraldine; Thom ... Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections / Taylor, Geraldine; Thom ... Human respiratory syncytial virus (HRSV) is a major cause of lower respiratory tract disease in children and the elderly for ...
... is a common respiratory virus that causes infections of the lungs and respiratory tract. It is very common in children but can ... Usually, this virus causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially ... Respiratory syncytial virus infection (RSV), is a common respiratory virus that causes infections of the lungs and respiratory ... Usually, this virus causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially ...
In this article we share the related information about Respiratory Syncytial Virus Infection, RSV is a prevalent viral ... Q1: What is Respiratory Syncytial Virus (RSV)?. A1: Respiratory syncytial virus (RSV) is a prevalent viral infection that ... Respiratory Syncytial Virus Infection: Navigating Infection, Prevention, and Management. Morgan James November 13, 2023 ... Respiratory Syncytial Virus Infection: Navigating Infection, Prevention, and Management. November 13, 2023 ...
Clinical Outcomes in Outpatient Respiratory Syncytial Virus Infection in Immunocompromised Children This study investigates the ... Direct Costs of Acute Respiratory Infections in a Pediatric Long-term Care Facility Acute respiratory infections in pediatric ... Respiratory Syncytial Virus, an Ongoing Medical Dilemma There is a large, unmet need for the development of vaccines, ... Early Occurrence of Influenza A Epidemics Coincided With Changes in Occurrence of Other Respiratory Virus Infections How does ...
increased morbidity from respiratory syncytial virus (RSV) infection, and. *chronic middle ear effusions [Cook and Strachan ... 2000]. The developing respiratory system may be more vulnerable to some airborne pollutants than the adult respiratory system. ... Respiratory exposures to air contaminants during the 1st year of life have a greater influence on the incidence and severity of ... The younger the child, the higher the respiratory rate and the higher the weight-adjusted dose of an air pollutant. For example ...
We use cookies to ensure that we give you the best experience on our website. If you click Accept all cookies well assume that you are happy to receive all cookies and you wont see this message again. If you click Reject all non-essential cookies only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click Find out more for information on how to change your cookie settings. ...
Respiratory Syncytial Virus Infection (RSV) is a very contagious virus that affects a majority of infants before age 2, and is ... About Respiratory Syncytial Virus Infection (RSV). by Jessica Schuman , Jan 19, 2017 , Education , 0 comments ... there is no drug available to treat the actual virus if an infant is infected. Treatment must focus on the infection and the ... Most childrens RSV appears as a common cold, but a few infants RSV can cause serious problems such as an infection in the ...
The Burden of Respiratory Syncytial Virus Infection in Young Children. New Engl J Med. 2009; 360(6): 588-98. ... Influenza Other Respir Viruses. 2014; 8: 507-15. *Hamid S, Winn A, Parikh R, et al. Seasonality of Respiratory Syncytial Virus ... CDC - Preventing RSV (Respiratory Syncytial Virus). *RSV Vaccination: What Older Adults 60 Years of Age and Over Should Know , ... Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis. J Infect ...
... a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalisation from respiratory syncytial virus infection ... Respiratory syncytial virus (RSV) is the most important cause of lower respiratory tract infection in infants and children. ... Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection Acta ... Epidemiology of Respiratory Syncytial Virus Infection in Preterm Infants Bernhard Resch1, *, Stefan Kurath1, Paolo Manzoni2. 1 ...
Learn how to recognize the signs and symptoms of this contagious infection. ... is a major cause of respiratory illness in young children. ... How Is Respiratory Syncytial Virus (RSV) Infection Diagnosed?. ... How Is Respiratory Syncytial Virus (RSV) Infection Treated?. Most cases of respiratory syncytial virus infection are mild and ... Virus respiratorio sincitial. What Is Respiratory Syncytial Virus (RSV)?. Respiratory syncytial (sin-SISH-ul) virus (RSV) is a ...
Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. ... Respiratory syncytial virus infection in the elderly. Eur J Clin Microbiol Infect Dis 1996;15:777-81. * Whimbey E, Couch RB, ... Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 1996; 97:137-40. * ... Respiratory syncytial virus (RSV), a common cause of winter outbreaks of acute respiratory disease, results in an estimated ...
  • Field evaluation of a respiratory syncytial virus vaccine and a trivalent influenza virus vaccine in a pediatric population. (microbiologyresearch.org)
  • Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections and hospitalization in infants under 1 year of age and there is currently no market-approved vaccine available. (ru.nl)
  • Human respiratory syncytial virus (HRSV) is a major cause of lower respiratory tract disease in children and the elderly for which there is still no effective vaccine. (unina.it)
  • Because the extent to which protection demonstrated in rodent models will translate to humans is unclear, we have exploited the calf model of bovine RSV (BRSV) infection, which mimics HRSV disease in children more closely than do experimental models of unnatural laboratory hosts, to evaluate the safety and efficacy of the PanAd3-RSV vaccine. (unina.it)
  • Prevention entails a combination of good hygiene, infection control, and vaccine programs. (gowellhealthtips.com)
  • Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. (medscape.com)
  • The seasonal epidemiology of hMPV appears to be similar to that of RSV, but the incidence of infection and illness appears to be substantially lower. (msdmanuals.com)
  • Systematic review and meta-analysis of respiratory syncytial virus infection epidemiology in Latin America. (bvsalud.org)
  • Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. (cdc.gov)
  • Only 10% (4/40) persons as an at-risk population for severe RSV disease of patients with RSV infection who were readmitted within might guide prioritization strategies for RSV vaccines 30 days had a positive swab specimen for the same virus at and therapeutics as they become available. (cdc.gov)
  • Generally, these findings are neither specific to RSV infection nor predictive of the course or outcome, except for the observation that infants who have the additional findings of atelectasis or pneumonia may have a more severe disease course. (medscape.com)
  • PF-07960613 is under development for the prevention of respiratory syncytial virus infection and coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). (pharmaceutical-technology.com)
  • Respiratory syncytial virus and human metapneumovirus infections cause seasonal lower respiratory tract disease, particularly in infants and young children. (msdmanuals.com)
  • For more than 20 years, effective prophylaxis against RSV infection has been achieved in the populations defined as being at high risk of severe or very severe disease due to RSV-clearly defined by the Sociedad Española de Neonatología (Spanish Society of Neonatology)-with the administration of a monoclonal antibody, palivizumab, which is very costly and has a short half-life. (analesdepediatria.org)
  • The development of a new monoclonal antibody with a longer half-life and of demonstrated efficacy and safety, nirsevimab, presents the opportunity to offer passive immunoprophylaxis universally to all healthy newborns to prevent these forms of disease in the period that they are most at risk of severe lower respiratory tract infection, chiefly in the first year of life. (analesdepediatria.org)
  • The current lack of understanding of the mechanisms by which antibodies can protect against RSV infection and disease or, alternatively, contribute to disease severity, hampers the design of safe and effective vaccines against this virus. (ru.nl)
  • We show that PanAd3-RSV alone and in combination with a modified vaccinia Ankara expressing the same HRSV antigens (MVA-RSV) induced neutralizing antibodies and cellular immunity in young seronegative calves and protected against upper and lower respiratory tract infection and pulmonary disease induced by heterologous BRSV challenge. (unina.it)
  • There was no evidence either of enhanced pulmonary pathology or of enhanced respiratory disease in vaccinated calves after BRSV challenge. (unina.it)
  • The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to notify clinicians and caregivers about increases in respiratory syncytial virus (RSV) activity across some parts of the Southeastern United States in recent weeks, suggesting a continued shift toward seasonal RSV trends observed prior to the COVID-19 pandemic. (cdc.gov)
  • Infants, young children, and older adults, especially those with chronic medical conditions, are at increased risk of severe disease from RSV infection. (cdc.gov)
  • This review focuses on the burden of respiratory syncytial virus (RSV) infection in preterm infants with and without chronic lung disease (bronchopulmonary dysplasia, BPD). (openmicrobiologyjournal.com)
  • Respiratory syncytial virus (RSV), a common cause of winter outbreaks of acute respiratory disease, results in an estimated 90,000 hospitalizations and 4500 deaths each year from lower respiratory tract disease among infants and young children in the United States (1). (cdc.gov)
  • Editorial Note: During the RSV season, health-care providers should consider RSV as a cause of acute respiratory disease in both children and adults. (cdc.gov)
  • however, children of any age who have underlying cardiac or pulmonary disease or are immunocompromised are at risk for serious complications from this infection. (cdc.gov)
  • In adults, RSV usually causes upper respiratory tract symptoms but can cause lower respiratory tract disease, especially in elderly and in immunocompromised persons (4-6). (cdc.gov)
  • In this review, we provide an overview of the literature on respiratory infections at mass gatherings, then describe the impact of novel coronavirus 2012 (nCoV), an emerging respiratory disease virus, on the preparations for mass gathering. (who.int)
  • This model closely mirrors human RSV disease and affords a unique opportunity to study interepithelial cell interactions, cytokine responses from cells of different donors, and ciliary activity of live cells undergoing RSV infection. (nih.gov)
  • However, in vulnerable populations, such as newborns, infants, the elderly and immune-compromised individuals, these opportunistic pathogens can also affect the lower respiratory tract, causing a more severe disease (e.g., pneumonia). (mdpi.com)
  • Cystic fibrosis (CF) is a disease of exocrine gland function that involves multiple organ systems but chiefly results in chronic respiratory infections, pancreatic enzyme insufficiency, and associated complications in untreated patients. (medscape.com)
  • Homeless persons experience with RSV infection were admitted to the intensive care unit higher rates of illness and death compared with the gen- (ICU), readmitted within 30 days, and received any anti- eral population, partly because of infectious diseases microbial drug compared with patients hospitalized with from lack of access to sanitation, crowding in shelters, influenza (Table 2). (cdc.gov)
  • Respiratory and Enteric Viruses Br, Div of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC. (cdc.gov)
  • Every orthopneumovirus is characterized as host-specific, and has a range of diseases involved with respiratory illness. (wikipedia.org)
  • Orthopneumoviruses can cause diseases that range from a less-severe upper-respiratory illness to severe bronchiolitis or pneumonia. (wikipedia.org)
  • RSV is the leading viral agent among pneumoviruses in pediatric upper respiratory diseases globally. (wikipedia.org)
  • Respiratory viruses infect the human upper respiratory tract, mostly causing mild diseases. (mdpi.com)
  • These infections include bronchiolitis, an inflammation of the small airways in the lung, and pneumonia , an infection of the lungs. (medlineplus.gov)
  • Overview of Pneumonia Pneumonia is acute inflammation of the lungs caused by infection. (msdmanuals.com)
  • Virus antigen within the lungs was found to be restricted essentially to the alveolar regions. (microbiologyresearch.org)
  • In addition, infection induced rapid interferon production within the lungs which was accompanied by an equally rapid rise in pulmonary natural killer (NK) cell cytotoxic activity. (microbiologyresearch.org)
  • IgG was the first class of virus-specific immunoglobulin to be detected in the lungs of infected animals after experimental infection. (microbiologyresearch.org)
  • Immunoglobulin class specific antibody response in serum, spleen, lungs and bronchioal- veolar washings after primary and secondary Sendai virus infection of germ free mice. (microbiologyresearch.org)
  • Respiratory syncytial virus infection (RSV) , is a common respiratory virus that causes infections of the lungs and respiratory tract. (evidentic.com)
  • Most children's RSV appears as a common cold, but a few infant's RSV can cause serious problems such as an infection in the small airway of the lungs (Bronchiolitis) or pneumonia. (breathepa.org)
  • It tends to give people a lot of upper respiratory symptoms, but when it really gets dangerous, it moves down into the chest and the lungs. (ajmc.com)
  • GSK -3888550A is under development for the prevention of respiratory syncytial virus infections. (pharmaceutical-technology.com)
  • Prevention of nosocomial respiratory syncytial virus infection. (ox.ac.uk)
  • RSV immune globulin intravenous (human) is available for prevention of serious RSV infections in some high-risk infants and children (9). (cdc.gov)
  • The ability to more accurately assess infection levels and predict which regions have higher infection risk in future time periods can instruct targeted prevention and treatment efforts, especially during epidemics. (nature.com)
  • The best methods of prevention of orthopneumovirus infection are covering cough and sneezing to prevent transmission of possible pathogens. (wikipedia.org)
  • Antimicrobial Stewardship and Infection Prevention-Leveraging the Synergy: A Position Paper Update. (medscape.com)
  • Safety of Palivizumab Stewardship in Conjunction with Infection Prevention and Control Strategies for Healthcare-Associated Respiratory Syncytial Virus Infections. (medscape.com)
  • Hospital-Onset Staphylococcus aureus Bacteremia Is A Better Measure Than MRSA Bacteremia for Assessing Infection Prevention: Evaluation of 50 US Hospitals. (medscape.com)
  • World Health Organization Influenza-Like Illness Underestimates the Burden of Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults. (ox.ac.uk)
  • BACKGROUND: Respiratory syncytial virus (RSV) surveillance is heavily dependent on the influenza-like illness (ILI) case definition from the World Health Organization (WHO). (ox.ac.uk)
  • Respiratory syncytial (sin-SISH-ul) virus (RSV) is a major cause of respiratory illness in children. (kidshealth.org)
  • Chickenpox is a common childhood illness caused by a virus. (kidshealth.org.nz)
  • Respiratory syncytial virus (RSV) infection is a common respiratory illness caused by a virus. (cattco.org)
  • IL18, but neither IFNγ nor IL12 was found in significantly greater concentrations in subjects with mild, nonhypoxic forms of bronchiolitis than in those with upper respiratory illness alone or hypoxic bronchiolitis. (utmb.edu)
  • Little is known about the incidence of infection and type of illness caused by influenza viruses in infants. (docksci.com)
  • BACKGROUND: Respiratory syncytial virus (RSV) is an important cause of respiratory illness worldwide, however, burden data on mother-infant pairs remain sparse in sub-Saharan Africa where HIV is prevalent. (itg.be)
  • METHODS: We enrolled pregnant women (≤20 weeks gestation) and followed them and their newborns weekly for up to 3-6 months post-partum, to document cases of acute respiratory illness (ARI). (itg.be)
  • CONCLUSION: HIV-infection may increase the risk of RSV illness among pregnant women. (itg.be)
  • We evaluated the impact of maternal HIV infection on the burden of RSV among mothers and their infants in western Kenya.METHODS: We enrolled pregnant women (≤20 weeks gestation) and followed them and their newborns weekly for up to 3-6 months post-partum, to document cases of acute respiratory illness (ARI). (itg.be)
  • Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. (cdc.gov)
  • Available at https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2023/09/maternal-respiratory-syncytial-virus-vaccination . (medscape.com)
  • Indication for immunoprophylaxis against severe RSV infection with nirsevimab, 2023-2024 season. (analesdepediatria.org)
  • A total of 4% (7/158) of adults given untreated chronic medical conditions, and higher rates a diagnosis of RSV infection died during hospitalization, of mental health issues and substance use ( 5 ). (cdc.gov)
  • We sought to determine whether increased hospital hospitalized with RSV infections versus those with in- readmission after hospitalization for RSV infection had fluenza in an urban medical center serving a region that other potential explanatory factors. (cdc.gov)
  • Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. (medscape.com)
  • Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. (medscape.com)
  • Infection by respiratory syncytial virus (RSV) is the most common cause of hospital admission in infants aged less than 1 year in Spain, and severe forms requiring hospitalization in newborns and infants aged less than 3 months and lower respiratory tract infections in infants resulting a high volume of primary care and emergency department visits are particularly frequent. (analesdepediatria.org)
  • Respiratory syncytial virus (RSV) is a frequent cause of hospitalization among infants. (nih.gov)
  • Clinicians should also talk to their patients about other vaccines available this fall to help prevent respiratory infections. (cdc.gov)
  • Currently animals are able to receive vaccines specific to their virus strand. (wikipedia.org)
  • General Manager at Sanofi Vaccines UK and Ireland, Rebecca Catterick, and Baroness Margaret Ritchie discuss the impact of Respiratory Syncytial Virus (RSV) in our society, with ideas on how it can be mitigated through enhanced understanding and proactive approaches to treatment. (politicshome.com)
  • Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES. (bvsalud.org)
  • A comparison of influenza and respiratory syncytial virus infections among infants admitted to hospital with acute respiratory infections. (docksci.com)
  • RSV is highly contagious and spreads through respiratory droplets, making crowded places, such as daycare centers and hospitals , potential hotspots for transmission. (gowellhealthtips.com)
  • RSV is extremely infectious and spreads by respiratory droplets, especially in crowded settings such as childcare centers and hospitals. (gowellhealthtips.com)
  • A3: RSV is highly contagious and spreads through respiratory droplets, making crowded places like daycare centers and hospitals potential hotspots for transmission. (gowellhealthtips.com)
  • RSV is an RNA virus, and transmission occurs primarily via respiratory droplets when a person coughs or sneezes, or through direct contact with a contaminated surface. (cdc.gov)
  • It spreads through droplets containing the virus when an infected person coughs or sneezes. (kidshealth.org)
  • Influenza spreads from person-to-person via respiratory droplets and requires close physical proximity for infection. (nature.com)
  • Respiratory syncytial virus (RSV) (see the image below) is the leading cause of lower respiratory tract infections (LRTIs) in infants and young children. (medscape.com)
  • Because ILI includes fever in its syndromic case definition, its ability to accurately identify acute respiratory tract infections (ARTI) caused by RSV in older adults is uncertain. (ox.ac.uk)
  • In developed countries, there are well-defined high-risk groups, generally with chronic underlying disorders, in whom infection with RSV is more likely to progress into severe lower-respiratory-tract infections. (openmicrobiologyjournal.com)
  • RSV is a common virus that can cause acute lower respiratory tract infections such as pneumonia and bronchiolitis. (politicshome.com)
  • Acute respiratory infections in pediatric long-term care facilities are associated with significant health and financial burdens. (medscape.com)
  • To compare patient management in Europe, the United States, and Australia, we analyzed the charts of 1,563 pediatric patients hospitalized with laboratory-confirmed RSV lower respiratory infections during recent RSV seasons. (nih.gov)
  • Generally, when we think about RSV infection in pediatric populations, every child before the age of 2 years [is likely to] be infected.During the COVID-19 pandemic, we saw RSV occurring year round, which is highly unusual. (ajmc.com)
  • Continuous research and global efforts are required to better understand RSV and develop comprehensive methods to lessen its impact, protect vulnerable people, and lower the overall burden of this respiratory virus. (gowellhealthtips.com)
  • We evaluated the impact of maternal HIV infection on the burden of RSV among mothers and their infants in western Kenya. (itg.be)
  • Chaves, Sandra S. / The impact of maternal HIV infection on the burden of respiratory syncytial virus among pregnant women and their infants, western Kenya . (itg.be)
  • viii] Furthermore, a lack of data on the prevalence of the virus means that the burden of RSV in infants and children could be greater than estimates suggest. (politicshome.com)
  • A Generalizable, Data-Driven Approach to Predict Daily Risk of Clostridium difficile Infection at Two Large Academic Health Centers. (medscape.com)
  • Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021. (msdmanuals.com)
  • What are the diagnostic practices for influenza and other respiratory virus in U.S. hospitals and laboratories? (medscape.com)
  • Respiratory Syncytial Virus Infection (RSV): Trends and Surveillance. (medscape.com)
  • Our data show significant promise for the use of oral fluid alone in RSV infection surveillance. (ox.ac.uk)
  • Nationally, the weekly percentage of positive detections reported to the National Respiratory and Enteric Virus Surveillance System (NREVSS), a national laboratory-based surveillance network, has remained below the season onset threshold of polymerase chain reaction (PCR) test positivity of 3.0% for 2 consecutive weeks. (cdc.gov)
  • RSV activity in the United States is monitored by the National Respiratory and Enteric Virus Surveillance System (NREVSS), a voluntary, laboratory-based system. (cdc.gov)
  • Reported by: National Respiratory and Enteric Virus Surveillance System collaborating laboratories. (cdc.gov)
  • Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. (cdc.gov)
  • Response to Alert on Possible Infections with Mycobacterium chimaera From Contaminated Heater-Cooler Devices in Hospitals Participating in the Canadian Nosocomial Infection Surveillance Program (CNISP). (medscape.com)
  • However, some infants, and people with weakened immune systems, can continue to spread the virus even after they stop showing symptoms, for as long as 4 weeks. (cdc.gov)
  • But sometimes infants and people with weakened immune systems can continue to spread the virus for as long as 4 weeks. (medlineplus.gov)
  • For protection against infection, young children mainly depend on their innate immune system and maternal antibodies. (ru.nl)
  • The interaction with Fc-receptors can lead to killing of virus-infected cells through a variety of immune effector mechanisms, including antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). (ru.nl)
  • In order to understand early events in the immune response to respiratory syncytial virus (RSV) infection, we studied the presence of various chemokines and cytokines in respiratory secretions of human infants with RSV infection. (utmb.edu)
  • Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. (cdc.gov)
  • Usually, this virus causes mild, cold-like symptoms. (evidentic.com)
  • RSV infection causes symptoms that vary from mild cold-like symptoms to severe difficulty breathing. (gowellhealthtips.com)
  • RSV infection presents a spectrum of symptoms, from mild cold-like manifestations to severe respiratory distress. (gowellhealthtips.com)
  • Most cases of respiratory syncytial virus infection are mild and don't need medical treatment. (kidshealth.org)
  • Rodentia: murine pneumonia virus Mild symptoms may include rhinitis, coughing, and decreased appetite. (wikipedia.org)
  • i] While in most cases the virus is mild,[ii] it can also lead to more severe complications as the leading cause of bronchiolitis in infants. (politicshome.com)
  • x] An RSV infection usually causes mild and self-limiting symptoms in children and adults which resolve within a couple of weeks. (politicshome.com)
  • What are the symptoms of respiratory syncytial virus (RSV) infections? (medlineplus.gov)
  • Healthcare personnel, childcare providers, and staff at long-term care facilities should stay home and not go to work when they have fever or symptoms of respiratory infection to reduce the spread of respiratory infections including RSV. (cdc.gov)
  • Maternal Respiratory Syncytial Virus Vaccination. (medscape.com)
  • Vaccination, particularly in high-risk individuals and the general public, is critical in reducing RSV infection and its repercussions. (gowellhealthtips.com)
  • RSV vaccination can help reduce RSV infection and its effects, especially in high-risk people and the general population. (gowellhealthtips.com)
  • In a recent webinar with CDC's Project Firstline and the American Medical Association (AMA), CDC Director Dr. Mandy Cohen discussed the impacts of the current respiratory virus season, the importance of vaccination, and the importance of effective risk communication to help built trust with the public. (cdc.gov)
  • Protecting Healthcare Personnel in Outpatient Settings: The Influence of Mandatory Versus Nonmandatory Influenza Vaccination Policies on Workplace Absenteeism During Multiple Respiratory Virus Seasons. (medscape.com)
  • Each year, 4-5 million children younger than 4 years acquire an RSV infection, and more than 125,000 are hospitalized annually in the United States because of this infection. (medscape.com)
  • The impact of RSV infection is not limited to only young children. (medscape.com)
  • Chest radiography is frequently obtained in children with severe RSV infection, but for the most part, typical findings are neither specific to RSV infection nor predictive of the course or outcome. (medscape.com)
  • Chest radiography is frequently obtained in children with severe RSV infection. (medscape.com)
  • RSV (and possibly hMPV) infection is suspected in infants and young children with bronchiolitis or pneumonia during RSV season. (msdmanuals.com)
  • However, a laboratory diagnosis may facilitate hospital infection control by allowing segregation of children infected with the same virus. (msdmanuals.com)
  • For five children sampled repeatedly from birth, antibody profiles in oral fluid quite consistently tracked those in paired sera, and RSV infections were detected by rising titers of antibodies of at least one Ig class. (ox.ac.uk)
  • RSV is a prevalent viral infection that primarily impacts the respiratory tract, particularly in infants and young children. (gowellhealthtips.com)
  • The infection primarily affects newborns and young children, where it is a primary cause of bronchiolitis and pneumonia. (gowellhealthtips.com)
  • Because of its yearly epidemics, Respiratory Syncytial Virus (RSV) is a serious public health concern, particularly among babies and young children. (gowellhealthtips.com)
  • A1: Respiratory syncytial virus (RSV) is a prevalent viral infection that mainly impacts the respiratory tract, especially in newborns and young children, and is the leading cause of bronchiolitis and pneumonia in that age group. (gowellhealthtips.com)
  • Many children were hospitalized for respiratory infections during the fall of 2014. (medscape.com)
  • Respiratory syncytial virus (RSV) is the most important cause of lower respiratory tract infection in infants and children. (openmicrobiologyjournal.com)
  • In humans, the orthopneumovirus that specifically impacts infants and small children is known as human respiratory syncytial virus. (wikipedia.org)
  • During cold and peak flu season, infants and small children have the option to receive monthly injections of small medication doses at a weak strength to help prevent virus/ host attachment. (wikipedia.org)
  • Human respiratory syncytial virus (RSV) is a common cause of respiratory infections in infants, young children, and elderly people. (authorea.com)
  • A survey of 604 Yemeni children younger than 2 years with acute respiratory infections identified respiratory syncytial virus (RSV) in 244 (40%), human metapneumovirus (HMPV) in 41 (7%) and RSV/HMPV coinfection in 25 (4%) children. (lstmed.ac.uk)
  • RSV infections occurred in younger children and were associated with more severe hypoxia than observed with HMPV. (lstmed.ac.uk)
  • Most adults and older children have had an RSV infection. (medlineplus.gov)
  • Some children younger than 24 months at high risk for RSV infection get a shot with antibodies to RSV to protect them. (medlineplus.gov)
  • Both influenza virus and RSV infections were diagnosed most frequently in children under the age of one year, and diagnosed more frequently in males than females. (docksci.com)
  • Both infections occurred more often, but were not more severe, in children from a conurbation than in those from 'rural' areas. (docksci.com)
  • In the present study, all the children under 5 years old with acute respiratory infections who were admitted to either Bristol Childrens' Hospital or Southmead Hospital during two winters from a circumscribed population were examined for respiratory virus infections as part of a collaborative study by the MRC Laboratory Working Party on RS Virus Infections. (docksci.com)
  • Patients It was intended to investigate all children under 5 years old admitted with acute respiratory infections. (docksci.com)
  • Of the 444 children tested in 1974/5, 61 (14 %) had proved infections with influenza A virus (26 resembling A/Port Chalmers/1/73, 16 resembling A/Scotland/840/74, 19 untyped, of which 16 were diagnosed by immunofluorescence only) and 124 (28 %) with RSV. (docksci.com)
  • Articles were included if they described original studies of confirmed RSV infection in children under 3 years of age, and had defined outcome variables. (qxmd.com)
  • Respiratory syncytial virus (RSV), the most common viral pathogen causing acute lower respiratory tract infection among children under five years old worldwide, still lacks specific therapeutic drugs. (researchsquare.com)
  • Results: Respiratory syncytial virus (RSV) is the most common viral bronchiolitis in young children. (benthamscience.com)
  • We found that 2, 4-DTBP-loaded micelles inhibited RSV infection in vitro and improved survival, lung pathology, and viral clearance in RSV-infected mice. (authorea.com)
  • Previously, chronic ethanol consumption was shown to prolong inflammation and delay viral clearance in respiratory syncytial virus (RSV)-infected mice. (cdc.gov)
  • Traditionally, antibody-mediated protection against viral infections is thought to be mediated by direct binding of antibodies to viral particles, resulting in virus neutralization. (ru.nl)
  • Importantly, neutralization is only one of many mechanisms by which antibodies can interfere with viral infection. (ru.nl)
  • Respiratory syncytial virus (RSV) antibody test is a blood test that measures the levels of antibodies (immunoglobulins) the body makes after an infection with RSV. (medlineplus.gov)
  • If the body has produced antibodies against RSV, then either a current or past infection has occurred. (medlineplus.gov)
  • Even though there is a medication that helps prevent high risk infants from getting RSV, there is no drug available to treat the actual virus if an infant is infected. (breathepa.org)
  • Respiratory syncytial virus, or RSV, is a common respiratory virus. (medlineplus.gov)
  • The American Academy of Pediatrics has released updated guidelines addressing palivizumab prophylaxis for respiratory syncytial virus (RSV). (medscape.com)
  • This response like the acute CTL response was found to be restricted to the lower respiratory tract. (microbiologyresearch.org)
  • The typical clinical picture of lower respiratory tract infection is not different in term and preterm infants, but rates of apnoeas are significantly increased in preterms, ranging from 4.9 to 37.5 percent with decreasing rates observed in more recent studies. (openmicrobiologyjournal.com)
  • The studies evaluated showed that RSV lower respiratory tract infection is associated with an increased risk for subsequent development of asthma/recurrent wheezing, and that this association becomes progressively smaller with increasing age. (qxmd.com)
  • 24 months and is characterized by respiratory distress, wheezing, and/or crackles. (msdmanuals.com)
  • Respiratory viruses can also exacerbate asthma and lead to various types of respiratory distress syndromes. (mdpi.com)
  • We evaluated an indirect enzyme-linked immunosorbent assay for the detection of RSV-specific immunoglobulin G (IgG) and IgA by using oral-fluid samples collected from individuals with RSV infections confirmed by an immunofluorescent antibody test. (ox.ac.uk)
  • Respiratory syncytial virus (RSV) is a frequent cause of acute respiratory infection and the most common cause of bronchiolitis in infants . (bvsalud.org)
  • Sendai virus-induced cell mediated cytotoxicity in vitro: the role of viral glycoproteins in cell mediated cytotoxicity. (microbiologyresearch.org)
  • To describe an in vitro model of human respiratory epithelium in primary cell culture linked with a computer microscope interface that allows evaluation and imaging of living RSV-infected respiratory epithelium. (nih.gov)
  • Respiratory illnesses caused by RSV - such as bronchiolitis or pneumonia - usually last about a week, but some symptoms, such as a cough, can last several weeks. (kidshealth.org)
  • This includes supplemental oxygen when indicated, management of respiratory secretions and maintaining hydration. (medscape.com)
  • Secretions can be analyzed for virus in the laboratory by means of culture, antigen-revealing techniques, or polymerase chain reaction (PCR). (medscape.com)
  • A lab test of nasal fluid or another respiratory specimen to check for RSV. (medlineplus.gov)
  • In that case, they identify the virus by testing nasal fluids. (kidshealth.org)
  • Isolating animals and humans that have a pneumovirus is the best way to prevent the virus from spreading. (wikipedia.org)
  • Human respiratory syncytial virus (HRSV) is the most known orthopneumovirus because of its direct correlation and importance in humans. (wikipedia.org)
  • Emergence of a novel swine-origin influenza A (H1N1) virus in humans. (cdc.gov)
  • Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. (cdc.gov)
  • GSK -3888550A is under clinical development by GSK and currently in Phase III for Respiratory Syncytial Virus (RSV) Infections. (pharmaceutical-technology.com)
  • Since July 1992, a total of 100 clinical and public health laboratories in 47 states have participated in NREVSS and have reported weekly to CDC the number of specimens tested for RSV by the antigen-detection and virus-isolation methods and the number of positive results. (cdc.gov)
  • However, despite the wide clinical application of andrographolide in viral infection, there are few relevant research focusing on its effects and mechanism on RSV infection so far. (researchsquare.com)
  • Clinical Relevance of the 2014 and 2015 National Healthcare Safety Network's Catheter-Associated Urinary Tract Infection Definitions. (medscape.com)
  • It's caused by a virus - often respiratory syncytial virus (RSV) or rhinovirus. (kidshealth.org.nz)
  • Other viruses such as human rhinovirus and coronavirus could be etiological agents. (benthamscience.com)
  • Probable or confirmed ongoing case of viral respiratory infection (including COVID-19, influenza, rhinovirus, etc.) at the time of enrollment. (who.int)
  • These illnesses typically begin with upper respiratory symptoms and fever, then progress over several days to dyspnea, cough, wheezing, and/or crackles on chest auscultation. (msdmanuals.com)
  • Influenza virus was isolated in monkey kidney or human embryo kidney cells, and RSV in bovine testis (Caul, Jacobs & Clarke, 1974), HEp-2, HeLa, or monkey kidney cells. (docksci.com)
  • The evolutionary dynamics of human influenza B virus. (cdc.gov)
  • Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? (mdpi.com)
  • This section discusses pharmacological interventions, respiratory support, and other strategies aimed at alleviating the impact of RSV infection, particularly in severe cases. (gowellhealthtips.com)
  • Herein, in this study we quantified RSV virus load, IL-6 and IL-8 in A549 cell supernatant, and found andrographolide decreased the viral load and attenuated RSV-induced inflammation. (researchsquare.com)
  • What is the main cause of severe acute respiratory infections on the US-Mexico border? (medscape.com)
  • Both viruses are important causes of severe acute respiratory infection in Yemen. (lstmed.ac.uk)
  • Impact of the International Nosocomial Infection Control Consortium (INICC)'s Multidimensional Approach on Rates of Central Line-Associated Bloodstream Infection in 14 Intensive Care Units in 11 Hospitals of 5 Cities in Argentina. (medscape.com)
  • Pulmonary A2 strain respiratory syncytial virus infection of BALB/c laboratory mice persisted for up to 7 days after initial infection with peak virus titres being recovered on day 4. (microbiologyresearch.org)
  • Clearance of persistent RSV infections in immunodeficient mice following transfer of primed T cells. (microbiologyresearch.org)
  • Primary respiratory syncytial virus infection in mice. (microbiologyresearch.org)
  • An association between MMP-9 and impaired T cell migration in ethanol-fed BALB/c mice infected with respiratory syncytial virus-2A. (cdc.gov)
  • BALB/c mice were randomly selected to consume 18% alcohol ad libitum for 8 weeks prior to infection with RSV-2A. (cdc.gov)
  • Lymphocyte recruitment was significantly reduced in the BAL 4 days after RSV infection in ETOH-RSV mice, whereas chemokine levels were the highest in this group at all experimental time points examined in comparison to RSV (p (cdc.gov)
  • How does the early occurrence of influenza epidemics impact outbreaks of other common seasonal viruses? (medscape.com)
  • This improved model predicts infections one week into the future as well as GFT predicts the present and does particularly well in regions that are most likely to facilitate influenza spread and during epidemics. (nature.com)